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Abstract
LAN LIU: Causal Inference with Interference
(Under the direction of Dr. Michael G. Hudgens)
Recently, increasing attention has focused on making causal inference when inter-
ference is possible, i.e., when the potential outcomes of one individual may be affected
by the treatment (or exposure) of other individuals. For example, in infectious diseases,
whether one individual becomes infected may depend on whether another individual
is vaccinated. In the presence of interference, treatment may have several types of ef-
fects. We consider inference about such effects when the population consists of groups
of individuals where interference is possible within groups but not between groups. In
the first part of this research, we assume a two stage randomization design where in
the first stage groups are randomized to different treatment allocation strategies and
in the second stage individuals are randomized to treatment or control conditional on
the strategy assigned to their group in the first stage. For this design, the asymptot-
ic distribution of estimators of the causal effects are derived when either the number
of individuals per group or the number of groups grows large. A simulation study is
presented showing that in various settings the corresponding asymptotic confidence in-
tervals have good coverage in finite samples and are substantially narrower than exact
confidence intervals. The methods are illustrated with two applications which consider
the indirect effects of cholera vaccination and an intervention to encourage voting. In
the second part of this research, we consider drawing inference about causal effects
in the presence of interference when two stage randomization is not possible. Inverse
probability weighted and doubly robust estimators are proposed for use in this setting.
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These estimators will be used to analyze data from an observational study on rotavirus
vaccination in Nicaragua.
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Chapter 1
Introduction and Literature Review
An important problem in epidemiological and clinical studies is how to make causal
inferences of treatments or agents; for example, does exposure to high levels of toxic
chemicals cause cancer? Does a new drug lead to a longer survival time? To assess
the causal effect, traditional literature assumes units are randomly assigned directly
to treatment or control. More often than not, the ideal randomization is violated or
unethical to implement in scientific studies. However, it is useful to describe methods
for drawing valid causal inferences in randomized setting before we consider more com-
plicated settings involving nonrandomized data. Also, in the traditional randomized
experiment, the potential outcomes that would be observed for a unit in either the
treatment or control condition are assumed not depend on the treatment assignment
of other units. Part of this condition is what Rubin (1980) refers to as the ‘stable unit
treatment value assumption’, or SUTVA for short. More recently there has been re-
search on relaxing SUTVA (see Hudgens and Halloran (2008), Tchetgen Tchetgen and
VanderWeele (2012) and VanderWeele and Tchetgen Tchetgen (2011)). In this docu-
ment we first review some classic approaches to making inferences about causal effects
using potential outcomes in randomization designed studies and then in observation-
al studies. In Chapter 2, we give the asymptotic distribution of estimators of various
causal effects in randomization studies and hence construct the Wald type of confidence
intervals (CI). These CIs are compared to existing exact CIs in simulation studies where
Wald CIs are significantly narrower while preserving good coverage. In Chapter 3, we
suggest using Hajek type estimators instead of inverse probability weighted estimators
in observational studies. Chapter 4 focuses on developing double robust estimators for
causal effects.
1.1 Motivating Examples
In the last decade a growing body of research has studied the effects of an inter-
vention when interference is at present. Hong and Raudenbush (2006) investigated
an case study of policy of retaining low-achieving children in kindergarten rather than
promoting them to first grade. Children were nested in classes and classes were nested
in schools. Interference was assumed to happen between children in the same school
but not between schools. In econometric studies, Sobel (2006) suggested the decision to
move of one household may also depend on other households in the same neighborhood.
The randomized trial described in Mvukiyehe and Samii (2011) studies the proximate
and medium-term effects of a newly designed intervention that (i) establishes village
“security committees” to enhance communication between local communities and a
peacekeeping mission and (ii) complements this security-based treatment with civic
and peace education. The communities were grouped based on location and proximity
to each other into ‘clans’. Interference may exist between communities in the same clan.
In this section, we introduce three studies that motivate the research in the following
chapters.
1.1.1 Herd Immunity Study in Bangladesh
The evaluation of killed oral cholera vaccines, which possess mild direct protection
to vaccinees, can also be judged based on indirect or herd protection when high levels
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of vaccine coverage are achieved. Ali et al. (2005) analyzed the first year of surveillance
data from a placebo-controlled trial of B subunit-killed whole-cell and killed whole-cell-
only oral cholera vaccines in children and adult women in Bangladesh. In the triple
blinded study (blinded to investigators, statisticians and patients), patients were ran-
domly assigned one of three letter-codes, which corresponded to three agents identical
in appearance.
When assessing cholera risk, the researchers grouped patients according to the baris
(patrilineally-related households living in clusters) they residing in. To define baris,
the authors made use of the Demographic Surveillance System of the region, which has
tracked all vital events of the local population since 1966. The bari level of vaccine
coverage was calculated as the number of vaccinated individuals divided by the number
of people who were eligible for participation in the tria by age and sex criteria. To
some extent, we can view the bari level as observational studies. It was assumed
that person-to-person transmission of cholera often takes place within these baris but
not across baris. Ali et al. (2005) found that the incidence of cholera tended to be
lower in unvaccinated individuals within baris with high vaccine coverage compared to
unvaccinated individuals within baris with low vaccine coverage.
1.1.2 Voting Encouragement Experiment
The study was carried out prior to the 2002 Congressional Primaries (Nickerson
(2008)). Households in Denver, CO, and Minneapolis, MN, with two registered persons
were included in the study and randomly assigned to one of the conditions: (1) receive
a Get Out the Vote (GOTV) message; (2) receive encouragement to recycle; (3) receive
no contact from the campaign. Each appeal was delivered through door-to-door visit.
Both Denver and Minneapolis are big cities with high density of two-voters households.
There were 486 households received the encouragement to vote and 470 households
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received the recycling treatment. The two key features of this study make it possible
to draw conclusion about contagion within household: only two-voter households are
considered and the treatment is administered to the first person who answers the door.
Thus, in a household received encouragement to vote, the coverage of the treatment is
exactly 50% in the household while that is 0% for either a placebo household or one
that received encouragement to recycle.
Nickerson (2008) found that both cities experienced a significant rise in the percent
of people voted in the election from the GOTV campaign. It was reported that 9.8%
more people in GOTV households voted compared to that in recycling encouragement
household among those who answered the door. The spillover effect was estimated
to be 6.0% and it is significant at the 0.1 level, that is for every 100 households that
receive the encouragement intervention, on average an additional six individuals will
vote despite never coming into direct contact with a canvasser. Thus Nickerson (2008)
concluded that interpersonal influence shapes the behaviors of people living in the same
household and the atomistic assumption was contradicted.
1.1.3 Diarrhea Vaccine Study in Nicaragua
The study was carried out in Leo´n, Nicaragua’s second largest city, with an es-
timated 2010 population of 200,000. The primary goal of the study was to evaluate
the efficacy of rotavirus vaccine in preventing and controlling the diarrhea episodes in
infants and young kids as well as to find out other characteristic factors that may help
reduce the risk of having rotavirus diarrhea.
The rotavirus vaccine was first introduced to Leo´n, Nicaragua in October 2006. In
2010, the Health and Demographic Surveillance Site-Leo´n (HDSS-Leo´n) was employed
to obtain a simple random sample of households from about 50 out of 208 randomly
selected geographical clusters of equal size (Becker-Dreps et al (2012)). Any child in
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the selected family under the age of 5 is eligible to be in the study. Rotavirus vaccine is
offered to any eligible child in the study at the age of 2, 4 and 6 months. However, due
to various reasons, the coverage of vaccine of at least one dose is about 67% after the
implementation of immunization program. Each individuals in the study were visited
by a field worker every 2 weeks for about a year (January 2010 to February 2011,
except during Christmas break). During each visit, information about the episodes
happened in the past 14 days were collected as well as other information about the
household such as the sanitation conditions, water source, or that of the mother or
the child such as maternal employment or age of the child. To better evaluate the
effectiveness of rotavirus vaccine, a historical study started in December 2000 and ended
in January 2003 in Leo´n, Nicaragua was revisited. Children in this study were viewed
as the placebo group. Becker-Dreps et al (2012) concluded that the rotavirus vaccine
has a significant indirect effect in that the rotavirus diarrhea incidence of unvaccinated
children after the introduction of the vaccine is lower than that before the introduction.
1.2 Causal Inference in Randomized Studies
1.2.1 Classic Causal Inference
As pointed out by Little and Rubin (2000), it is complicated and challenging to
define “cause” rigourously, but for empirical research, the idea of the causal effect of
an agent or treatment makes it more straightforward and practically useful to quantify
“cause.” One possible method is to define causal effects by means of potential outcomes.
The definition of causal effects using potential outcomes is often referred to as Rubin’s
Causal Model (Little and Yau (1998), Frangakis and Rubin (2004)), but the formal
notation was introduced by Neyman in the context of randomization-based inference
(Robins (1989), Rubin (1990)). This framework has been widely employed in empirical
research in various fields such as economics (Haavelmo (1944), Robins and Greenland
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(1996), Pratt and Schlaifer (1988), Tinbergen (1930)), epidemiology (Greenland and
Robins (1986), Robins (2000), Robins et al. (1992), Robins et al. (2000)), social and
behavioral sciences (Sobel (1990, 1995), Wilkinson (1999)), statistics (Rubin (2004),
Pratt and Schlaifer (1984)) and elsewhere.
The key problem for inference is that once the treatment is adopted, only one
of potential outcomes is observed, the one corresponding to the treatment actually
assigned. This feature is referred to as “counterfactual” in the causal inference literature
(Morgan and Winship (2007)). For example, if we assign vaccine to prevent the flu,
then we do not observe the outcome we would have seen if vaccine were not assigned. In
other words, the outcomes under control is missing for individuals assigned treatment
and that under treatment is missing for individuals in control group. Thus, causal
inference can be regarded as a problem of drawing inference when half of the potential
outcomes are ‘missing’. This viewpoint gave rise to a formal framework that extended
the idea beyond randomized experiments to accommodate unexpected missing data
and noncompliance (Rubin (1974, 1977, 1978)).
Following the existing literature, with a binary treatment there are two potential
outcomes for each individual, one under treatment and the other under control. The
potential outcome is well defined in this way only if two conditions are satisfied. First,
there are not multiple versions of the treatment. Second, the potential outcomes that
would be observed for a unit in either the treatment or control condition do not depend
on the overall set of treatment assignments. These two conditions together are what
Rubin (1980) refers to as the “stable unit treatment value assumption,” or SUTVA.
Manski (2012) addressed the latter assumption as “individualistic treatment response”
(ITR) and viewed it as a restriction of the form of treatment response function.
Primarily, there are three formal statistical modes of causal inference, one due to
Fisher (1932), one due to Neyman (1990) and the third arises from a Bayesian point
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of view. The Fisher’s sharp null hypothesis states that both treatments have exactly
the same outcomes, i.e., Y (1) = Y (0) for all units, where 1 stands for treatment and
0 for placebo. Under the sharp null hypothesis, there is no missing value since all the
potential outcomes can be identified from the observed outcome Y obs (note Y (0) =
Y (1) = Y obs). Furthermore, the value of any test statistic, T , such as Y (1)− Y (0),
can be computed and the P value of with can be obtained. Little and Rubin (2000)
pointed out that the Fisher’s sharp null model is too restricted and a small P value
does not necessarily imply that deviations from the null hypothesis are of importance.
However, there is still worthwhile to obtain such a P value when one claims evidence
for a treatment difference.
Neyman’s form of randomization-based inference, on the other hand, has a direct
mapping to Neyman’s (1934) classic article on randomization-based (also known as
design-based) inference in surveys. Essentially, one needs to construct an unbiased
estimator of the causal effect and an unbiased (or upwardly biased) variance estimator
for it. Central limit theorem can be applied to attain the normality of the estimator
when the sample size is large enough and hence a Wald confidence interval (CI) can
be construct to assess the region of uncertainty. More explicitly, let Yˆ (0) and Yˆ (1)
denote the sample means of the outcomes of individuals assigned to treatments 0 and
1, respectively. The average causal effect is chosen to be Y (1)− Y (0), where Y (1)
is the average outcome among the treated individuals and Y (0) is that among the
untreated. It can be shown that Yˆ (1)− Yˆ (0) is unbiased for Y (1)−Y (0) under simple
random assignment of treatments. Let n1 denote the number of units assigned the first
treatment and n2 units assigned the second treatment, thus the estimated variance is
se2 = s21/n1+s22/n2, where s1 and s2 are the sample variances of two treatment groups.
Unless causal effects are the same across all the individuals (also called ‘additivity’),
the sample variance se2 is positively biased. The standard 95% confidence interval for
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Y (1)−Y (0) is Yˆ (1)− Yˆ (0)± 1.96se, which, in large enough samples, includes Y (1)−
Y (0) in 95% of the possible random assignments. As commented on by Little and Rubin
(2000), Neyman’s form of inference is aiming at evaluations of procedures for causal
inference rather than telling us what to do. The Bayesian approach is beyond the scope
of our discussion here. In Chapter 2, we will adopt Neyman’s form of randomization-
based inference.
1.2.2 Interference
We say ‘interference’ is present if the treatment of one individual affect the potential
outcome of another individual. Experimental and observational studies often involve
treatments with effects that ‘interfere’ across units through spillover or other forms of
dependency. Sometimes this interference is a nuisance, in which case we might design
the study to isolate units as much as possible from potential interference. This may
not always be feasible, however. Also, the spillover effects may be of intrinsic interest.
Treatments may be applied to people in an existing network, and we may wish to study
how effects transmit to peers in the network.
There are a number of research papers trying to demystify the role of interference in
various scientific areas. In infectious disease studies, the susceptibility of an individual
to the disease may depend not only on his own vaccine status, but on that of others
as well. Halloran and Struchiner (1995) defined ‘conditional direct causal effects’ to
be the averages effects of vaccination conditional on the subject’s exposure status. By
assuming ‘all exposures to infection are discrete and equivalent’, they circumvent the
interference problem and instead focus on the difference between the transmission prob-
abilities among the vaccinated and unvaccinated individuals. In economics, Angelucci
and De Giorgi (2009) employed village-level randomized experiment to demonstrate
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that the strong impact of a cash transfer program may be due to large positive spill-
overs. More specifically, the comparison between ineligible households from treated
villages to households from untreated villages reveal a positive impact on the consump-
tion of ineligible households of the policies. In such randomization study, spill-over
effect can be measured directly. Sobel (2006), however, took a different approach by
defining unit effects for any allocation of the population units to treatment groups.
Based on that, he defined average effects in a specific allocation of the units to treat-
ments. Although his method was illustrated by a “Moving to Opportunity” (MTO)
study, such techniques can be apply to other settings as well.
When interference is present, the difficulty of analyzing data in a sensible way
increases. The first and foremost problem is how to define the potential outcomes.
As mentioned, the classic interference literature assumes that each individual has two
potential outcomes. This is generally not true when the interference is at present.
Imagine there are two people in the study, the outcome of one individual cannot be
fully determined by his own treatment but also by the other’s. More generally, in a
population of size n, the number of potential outcome for each individual can be as
many as 2n if any interference is possible. Also, as stated by Rosenbaum (2007), simple
comparison such as take the difference of the treated and untreated can no longer reflect
the treatment effects since the interference makes the effect inherently more complex.
Available statistical tools are also limited. For instance, Fisher’s sharp null hypothesis
of no treatment effect implicitly assumes no interference, thus this randomization test
cannot be used to test no effect in the presence of interference.
Hudgens and Halloran (2008) defined the average potential outcome, that is, the
expected outcome of an individual given his treatment averaging over all the possible
combinations of treatment assignment of others. Thus, there are only two average
potential outcome for each individual even when individuals interfere with each other.
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Researches on the simplification on the structure of interference are carried out. For
example, the stratified interference states that the interference is possible only among
the individuals in the same group but not across. Further, Hudgens and Halloran (2008)
considered the situation where the outcome of one individual is allowed to depend on
his treatment as well as the coverage of the group he belongs to. Thus, under certain
randomization, the number of all potential outcome decreases greatly. For a study
where individuals interfere with each other, the potential outcomes can be regarded as
a function of the treatment vector of other members in the population. Manski (2012)
commented that the no interference, the partial interference and other interference
structure assumption are merely special cases of the functional form of the potential
outcomes. Another commonly used approach assumes that interference is of a simple
parametric form confined to units that are near one another in time or space. For
example, Verbitsky and Raudenbush (2004) modeled the neighbourhood crime rate in
Chicago as a function of community policing implemented in it as well as surrounding
areas. This approach is useful when applicable but is of little use when interference
may be widespread and of uncertain form. In this case, nonparametric methods that
assuming nothing at all about the structure of the interference between units makes
more sense.
When the interference exists in the population, there are more effects to investigate
before reaching the conclusion of the efficacy of a treatment or intervention. Hudgens
and Halloran (2008) defined direct, indirect, total and overall effects and proposed un-
biased estimators for them. Under the stratified interference assumption, the variance
estimator of those causal effect estimators are also developed. They were shown to be
unbiased when the additivity holds and positively biased otherwise. Tchetgen Tchetgen
and VanderWeele (2012) relaxed the stratified interference assumption when developing
variance estimators. They came up with simple yet conservative estimation of variance,
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as an unbiased estimator of an upper bound for the variance is often a useful measure of
uncertainty. McConnell et al. (2010) applied multi-level designs to a large-scale voter
mobilization experiment conducted in Chicago during a special election in 2009 us-
ing the social pressure mailings pioneered by Gerber, Green and Larimer (2008). They
found some evidence of within-household spill-overs but no evidence of spill-overs across
households. The advantage of their method is the inference is no longer restricted under
SUTVA or just interference within group not across groups. However, they adopted a
parametric way of analyzing data, which may provide misleading result if confounders
are not all taken into considerations.
1.3 Observational Studies
Unlike an ideal randomized trial, the response of individuals in different treatment
groups should not be compared directly in observational studies. This is because the
units in one treatment group may differ greatly from the units in the other treatment
group. An idea is to modify the observational study as much alike as possible into a
randomized trial. For example, if (i) the treatment selection mechanism can be predict-
ed by the measured covariates (conditional exchangeability), (ii) the probability of the
treatment allocation is positive conditional on covariates (positivity) and (iii) although
the treatment are not assigned by the investigator but correspond to certain interven-
tion (consistency), then the observational study can emulate a conditional randomized
experiment. That is to say, to endow causal inference from the observational study,
one needs to provide an observational study which can be modified into a conditional
randomized study and describe the randomization mechanism that one would like to
carry out but couldn’t. Recall that in an ideal randomization trial, the exchangeability,
positivity and consistency are all satisfied. However, in observational studies, these
three assumptions, however careful an investigator might be about and no matter how
11
many covariates have been collected, can never be guaranteed by study design.
In reality, a randomization study can bear the intricateness as much as an observa-
tional study. For example, a randomized trial with possible severe adverse events may
result in censoring or non-compliance which causes selection bias. Or, some predictor
or outcome (e.g., SNPs) maybe unable to observed directly or the study is unable to
be blinded which leads to measurement error. Above all, randomization study is not
always ethnical, practical or timely to conduct. These problems all beg the need for
appropriate analytical method for observational studies.
1.3.1 Classic Methods
As mentioned, once the conditional exchangeability, positivity and consistency are
satisfied, an observational study emulates a conditional randomization study, thus the
methods of the latter could be applied. Following Rosenbaum (2002), overt bias, de-
fined as visible, recorded pretreatment differences, can be removed by post-study ad-
justments; hidden bias, defined as unobserved pretreatment differences, must be studied
by other technics such as sensitivity analysis. There are two common methods to ad-
just for the overt bias: the stratification or matching can be used to compute the
conditional causal effects in certain subsets of the population while inverse-probability
weighting (IPW) (or the equivalent ‘standardization’ method) can be used to compute
the marginal causal effects in the entire population.
Rosenbaum and Rubin (1983) suggested the use of balancing scores, that is to group
the individuals that have similar propensity scores. Although such method cannot
guarantee the units in different treatment group to be exactly the same in all covariates,
it can at least achieve balance in terms of the selection mechanism and thus make the
comparison under different treatment exposure meaningful. It has been shown both
in theory and in empirical studies that such adjustment is sufficient to eliminate the
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bias caused by the observed covariates. More generally, covariate adjustment plays an
important role in making inference in non-randomization studies especially when the
treatment selection mechanism is unknown. In observational studies with unknown
propensity score but without hidden bias, if conditional on a sufficient estimator for
the unknown parameters in the propensity model, the conditional assignment follows
a known distribution. And thus, the methods and results obtained in randomization
studies can be generalized without much difficulty in observational studies.
The IPW estimator for the mean response under treatment z can be described as
Ŷ (z) =∑i 1(Zi = z)Yi(z)/{nPr(Zi|Li)}, where Zi is the random variable of treatment
for individual i = 1, . . . ,n, Yi(z) is the potential outcome under treatment z and Li is
the covariates determines the choice of treatment. In the survey sampling literature,
the IPW estimator is known as the Horwitz Thompson estimator. The IPW procedure
simulates what would have been observed if the covariates had not been used to decide
the treatment. Similar as in the randomization studies, there are many settings where
the no interference assumption is violated in non-experimental studies. Under ignor-
ability and positivity assumption, Tchetgen Tchetgen and VanderWeele (2012) proved
that the average potential outcome can be unbiasedly estimated by the ‘generalized
IPW estimator’ in the presence of interference. In Chapter 3, we propose the Hajek
estimator to improve the ‘generalized IPW’ estimator for observational studies when
interference is present. For the following chapters, we always assume that observational
studies of interest are free of hidden bias.
1.3.2 Doubly Robust Estimators
There are two main criticism against IPW estimator: one in terms of efficiency and
the other of robustness. Note that when the propensity score tends to 0, the estimator
is unbounded, which leads to large variance. Empirical studies have shown that, the
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IPW estimator is sensitive to the estimation of the propensity score. The doubly robust
estimator, on the other hand, is shown both theoretically and empirically to be effective
to make the correct inference in observational studies. There are two ways to adjust
for the missing outcome when the missing is beyond the control of the investigator.
One way is to model the missing mechanism while the other is to impute the missing
outcomes through covariates. The doubly robust procedure takes the both models into
account and the conclusion is valid when either of the model is right.
Previous literature has developed various doubly robust estimators (Sa¨rndal et al.
(2003), Lunceford and Davidian (2004), Bang and Robins (2005), Kang and Schafer
(2007)). For example, Cassel et al. (1976, 1977) proposed a family of “generalized
regression estimators” of population means based both on the outcome predicted and
the propensity scores. The estimator can be expressed as ŶBC−OLS(z) = ŶOLS(z) +∑
i 1(Zi = z)p̂i−1i ε̂i(z), where ŶOLS(z) is the ordinary least square estimator for the
population mean if everyone in the population assigned treatment z, p̂ii = Pr(Zi = z)
and ε̂i(z) is the estimated residuals. Thus, if the study potential outcome model is true,
then E[ε̂i(z)] = 0 which leads to the second term in the ŶBC−OLS(z) formula 0 for any
p̂ii. If the propensity score model is true, the the second term consistently estimates
the bias of the first term.
As commented by Tsiatis and Davidian (2007), the property of an estimator can be
fully understood by investigating the influence function. The situations where either
of the potential outcome model or the propensity score is correct can be viewed from
a semi-parametric standing where the distribution of covariates are always unspecified.
It was shown that when at most one model is misspecified, the standardized DR es-
timator is asymptotically linear in influence functions and thus achieves consistency
and asymptotically normality. However, to our knowledge all methods on DR inference
assume no interference. In Chapter 4, we are going to apply the DR procedure for
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observational studies when interference is present.
1.4 Summary and Proposed Research
In summary, assessing the causal effect of treatment with interference is an impor-
tant goal. However, interest in interference can make inference challenging even when
randomization is employed. Specifically, previous literature have develop the estimators
for different causal effects but further investigation about the asymptotic distribution
needs to be undertaken. Additionally, published approaches for analyzing data from
observational studies under various types of interference are limited.
Accordingly, we first develop methods for randomization-based causal inference with
interference. The asymptotic distribution of various causal effects: direct, indirect,
overall and total effect at both individual and group level will be derived. Moreover,
Wald type of CI will be proposed and compared to exact CI. The methods are illus-
trated with two applications which consider the effects of cholera vaccination and an
intervention to encourage voting. Second, we propose modified IPW estimators for use
in observation studies where interference may be present. The modified IPW estimators
will be shown to be asymptotically unbiased and have smaller variance compared to
the IPW estimators proposed by Tchetgen Tchetgen and VanderWeele (2012). Lastly,
we propose doubly robust estimators for use in observational studies when interference
may be present. These estimators are appealing in the sense that the estimators are
consistent when either the propensity or the potential outcome model is right. Simu-
lations are carried out to show the bias and mean square error for various estimators.
The modified IPW estimators and the doubly robust estimators are illustrated with an
application which considers the effects of rotavirus vaccination.
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Chapter 2
Large Sample Randomization Inference with Interference
2.1 Introduction
When assessing the causal effect of a treatment or exposure, it is typically assumed
that individuals (or units) do not interfere with each other (Cox 1958). This assumption
is part of the stable unit treatment value assumption (SUTVA) (Rubin 1980). Under
the no interference assumption, the potential outcomes of any individual are assumed
to be determined solely by the treatment of that individual, unaffected by the treat-
ment of other individuals under study. However, in many settings this assumption may
not hold. For example, in vaccine studies, the outcome of an individual may depend
not only on that individual’s vaccine status but also on the vaccination status of other
individuals (Halloran and Struchiner 1995). In educational studies, a student’s aca-
demic performance may depend on the retention or promotion of that student as well
as of fellow classmates (Hong and Raudenbush 2006). In econometric studies, inter-
ference may be present between households in the same neighborhood (Sobel 2006) or
other settings where individuals interact socially (Manski 2012). Interference can occur
within an individual over time, e.g., as in functional MRI studies (Luo et al. 2012), or
between units that are proximal spatially (e.g., Zigler et al. 2012). Rosenbaum (2007)
presents several other examples where interference may be present.
Increasing attention has been placed on relaxing the no interference assumption
(see Tchetgen Tchetgen and VanderWeele (2012) and references therein). Inference in
this setting is particularly interesting because a treatment may have different types
of effects, but challenging because individuals may have many potential outcomes due
to interference. One approach has been to consider settings where individuals can be
partitioned into groups such that interference is possible between individuals within
the same group but not across groups. This is sometimes called ‘partial interference’
(Sobel 2006), a terminology adopted here. In the nomenclature of Manski (2012),
partial interference is an example of a ‘constant treatment response’ where the ‘reference
groups’ are ‘treatment invariant’ and ‘symmetric’. The partial interference assumption
will be reasonable when groups are sufficiently separate socially, temporally, or spatially.
Drawing inference about treatment effects often relies on knowledge or modeling
of the mechanism by which individuals are assigned or select treatment. Assuming
partial interference, one possible assignment mechanism is a two stage randomization
design, where in the first stage groups are randomized to different treatment allocation
strategies and in the second stage individuals are randomized to treatment or control
conditional on the strategy assigned to their group in the first stage. For example,
schools might be randomized to high or low vaccine coverage, and then students in
the schools randomized to vaccine or control with vaccination probability dependen-
t on whether their school was assigned to high or low coverage (Longini et al. 1998).
Similarly, Borm et al. (2005) described a trial where general practitioners were random-
ized to two allocation strategies and then different proportions of each practitioner’s
patients were randomly assigned either a traditional or new method of care. Sinclair
et al. (2012) conducted a two stage randomization experiment to determine the direct
and indirect (or ‘spillover’) effects of social pressure mailings on voter mobilization in a
special election in 2009. In that study zip-codes were randomly assigned to one of four
allocation strategies, and then households within a zip-code were randomly assigned to
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receive mailings (postcards) conditional on the allocation strategy assigned to that zip-
code. For other examples, see Duflo and Saez (2003) and Ichino and Schu¨ndeln (2012).
This two-stage randomization design has been referred to as split-plot or pseudo-cluster
randomization.
Assuming partial interference and a two stage randomization design, Hudgens and
Halloran (2008) proposed unbiased estimators for different causal effects of treatment.
They also derived variance estimators which under certain assumptions are conservative
unless the corresponding causal effect is additive. These results can be viewed as gener-
alizations of the classic results of Splawa-Neyman (1923) to the setting of interference.
In this paper, the large sample distributions of the causal effect estimators proposed
by Hudgens and Halloran (2008) are derived for two stage randomization studies. The
outline of the remainder of this paper is as follows. In Section 2.2 we introduce no-
tation and define various causal effects. Unbiased estimators of these effects and the
corresponding variance estimators are reviewed briefly in Section 2.3.1. The asymptotic
distributions of these estimators are then derived when either the number of individ-
uals within the groups grows large (Section 2.3.2.1), or the number of groups grows
large (Section 2.3.2.2). These results can be utilized to construct Wald type confidence
intervals (CIs) or tests for the different treatment effects. In Section 2.4 a simulation
study is presented comparing Wald CIs with CIs based on Hoeffding and Chebyshev
inequalities. Section 2.5 includes two applications which consider the various effects
of a cholera vaccine and an intervention to encourage voting. Proofs of the results in
Section 2.3 and some technical details regarding the voting encouragement analysis are
given in the Appendix.
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2.2 Notation, Assumptions and Estimands
Consider a population of m groups with ni individuals in group i for i = 1, . . . ,m.
Suppose individuals can receive treatment or control, denoted by 1 or 0. Let zij denote
the treatment indicator for individual j in group i, where zij = 1 indicates treatment
and zij = 0 denotes control. Let zi(−j) denote the vector of treatment indicators for the
individuals in group i other than individual j and let zi = (zij , zi(−j)) denote the vector
of treatment indicators for all individuals in group i. Let yij(zi) = yij(zij , zi(−j)) denote
the potential outcome of individual j when individuals in group i receive treatment
zi. Randomization based inference is employed in this paper wherein the potential
outcomes are viewed as fixed (i.e., non-random) features of the population of ∑mi=1ni
individuals. Note the notation yij(zi) encompasses the partial interference assumption
that the outcome for individual j does not depend on the treatment of individuals in
groups i′ 6= i.
Just as individuals can receive treatment or control, suppose groups can take on
different treatment allocation strategies corresponding to the proportion of individuals
within the group that receive treatment. For simplicity we consider only two allocation
strategies, denoted by α1 and α0. For instance, α1 could correspond to assigning treat-
ment to 50% of individuals in a group and α0 could correspond to assigning treatment
to 10% of individuals in a group. Let gi = s when allocation strategy for group i is αs
and let g = (g1, . . . ,gm) denote the vector of group level allocation strategies.
Assume a two-stage randomization design where in the first stage groups are as-
signed allocation strategies α1 and α0. Denote the random assignment indicator for
group i by Gi and let G= (G1, . . . ,Gm). Let l =
∑m
i=1Gi denote the number of groups
assigned allocation strategy α1. Assume allocation strategies are assigned using per-
mutation randomization such that l is fixed for some integer l ∈ {1, . . . ,m− 1}, i.e.,
Pr(G= g) = 1/
(
m
l
)
for all g such that ∑mi=1 gi = l and Pr(G= g) = 0 otherwise. In the
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second stage of randomization, individuals are randomly assigned treatment or control
conditional on Gi = gi from the first stage. Let the individual treatment assignmen-
t of individual j in group i be denoted by Zij and let Zi = (Zi1, . . . ,Zini) such that
the observed outcome for individual j is yij(Zi). Throughout, it is assumed that the
assignment of an individual to a particular treatment is equivalent to receipt of that
treatment, i.e., there is perfect compliance. Likewise, it is assumed groups are always
compliant with their assigned allocation strategy. Let kiαs =
∑ni
j=1Zij denote the num-
ber of individuals in group i assigned treatment when group i is assigned allocation
strategy αs. Assume that treatment is assigned using permutation randomization such
that kiαs is fixed given Gi. Let Rnk denote the set of vectors of length n with ele-
ments 0 or 1 that sum to k, i.e., Rnk = {v ∈ {0,1}n :
∑n
i=1 vi = k}. Under the two stage
randomization design described above, g ∈Rml , zi ∈Rnikiαs and zi(−j) ∈R
ni−1
kiαs−zij .
Define the average potential outcome for individual j in group i when individual j
is assigned treatment z and group i is assigned allocation strategy α1 by
yij(z,α1) =
∑
zi(−j)∈Rni−1kiα1−z
yij(zij = z,zi(−j))Prα1(Zi(−j) = zi(−j) | Zij = z).
See VanderWeele and Tchetgen Tchetgen (2011) for alternative approaches to defining
average potential outcomes for an individual. Averaging over individuals, define the
group average potential outcome under group allocation α1 and individual treatment
assignment z as yi(z,α1) =
∑ni
j=1 yij(z,α1)/ni. Similarly, averaging over groups, define
the population average potential outcome as y(z,α1) =
∑m
i=1 yi(z,α1)/m. Define the
marginal individual average potential outcome by yij(α1) =
∑
z∈Rnikiα1
yij(z)Prα1(Zi =
z), that is, the average potential outcome for individual j in group i when group i
is assigned α1. Similarly, define the marginal group and population average potential
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outcomes by yi(α1) =
∑ni
j=1 yij(α1)/ni and y(α1) =
∑m
i=1 yi(α1)/m.
Various causal effects can be defined by considering contrasts of different average
potential outcomes. For example, at the group level, a direct effect can be defined as
DEi(α1) = yi(1,α1)−yi(0,α1). That is, DEi(α1) is the difference between the average
potential outcome when group i receives allocation strategy α1 and an individual in
that group receives treatment compared to when an individual in that group receives
control. At the population level define the direct effect DE(αs) = y(1,αs)−y(0,αs) for
s= 0,1, the indirect effect IE(α1,α0) = y(0,α1)−y(0,α0), the total effect TE(α1,α0) =
y(1,α1)− y(0,α0), and the overall effect OE(α1,α0) = y(α1)− y(α0). In words, the
indirect (or spillover) effect compares the average potential outcome when an individual
receives control and their group receives allocation strategy α1 compared to when their
group receives α0. Because the individual treatment assignment is held fixed, the
indirect effect will be non-zero only if interference is present. Note that the indirect
effect can also be defined for individuals who receive treatment, i.e., in terms of y¯(1,αs)
for s= 0,1, but for simplicity we do not consider this other indirect effect here. The total
effect equals the sum of the direct and indirect effects, while the overall effect provides a
single summary measure of the effect of allocation strategy α1 versus α0. See Tchetgen
Tchetgen and VanderWeele (2012) for further discussion about these estimands.
Assuming only partial interference, an individual in a group with ni individuals will
have 2ni potential outcomes. For groups of even moderate size the large number of
potential outcomes per individual makes inference challenging. One possible additional
assumption about the structure of interference that reduces the number of potential
outcomes considerably is:
yij(zi) = yij(z′i) for all zi, z′i ∈Rnikiαs such that zij = z
′
ij . (2.1)
Assumption (2.1) has been referred to as ‘stratified interference’ (Hudgens and Halloran
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2008) and ‘anonymous interaction’ (Manski 2012). This assumption might be appro-
priate when the potential outcome of any individual in a group is thought to be affected
only by that individual’s treatment and the aggregate treatment assignment of others in
the same group. For example, consider a study of vaccines in children attending school
and assume no interference between schools. Assumption (2.1) implies the outcome for
an individual vaccinated child will be the same when k−1 schoolmates receive vaccine
regardless of which particular k−1 schoolmates are actually vaccinated. Under (2.1),
the number of potential outcomes reduces from 2ni to 2ni for any individual in a group
of size ni. Given permutation allocation strategy αs is assigned to group i, individual j
will have only two potential outcomes depending on whether zij = 1 or zij = 0. That is,
yij(zij , zi(−j)) = yij(zij ,αs) for all zi ∈ Rnikiαs . In the sequel, the stratified interference
assumption (2.1) is made throughout. Thus for notational simplicity yij(z,αs) will be
denoted by yij(z,αs) for z,s= 0,1.
2.3 Inference
2.3.1 Estimators
Hudgens and Halloran (2008) derived unbiased estimators for the causal estimand-
s defined in Section 2.2 above. Specifically, assuming partial interference and two
stage permutation randomization, a conditionally unbiased estimator for yi(z,αs) giv-
en Gi = s is Ŷi(z,αs) =
∑ni
j=1 yij(Zi)1(Zij = z)/
∑ni
j=1 1(Zij = z) and an unbiased es-
timator for y(z,αs) is Ŷ (z,αs) =
m∑
i=1
Ŷi(z,αs)1(Gi = s)/
m∑
i=1
1(Gi = s), where 1(·) is
the usual indicator function. At the group level a conditionally unbiased estima-
tor given Gi = s of the direct effect is D̂Ei(αs) = Ŷi(1,αs)− Ŷi(0,αs), and at the
population level unbiased estimators for the direct, indirect, total, and overall ef-
fects are D̂E(αs) = Ŷ (1,αs)− Ŷ (0,αs) for s = 0,1, ÎE(α1,α0) = Ŷ (0,α1)− Ŷ (0,α0),
T̂E(α1,α0) = Ŷ (1,α1)− Ŷ (0,α0) and ÔE(α1,α0) = Ŷ (α1)− Ŷ (α0), where Ŷi(α1) =
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∑ni
j=1 yij(Zi)/ni, Ŷ (α1) =
∑m
i=1 Ŷi(α1)1(Gi = 1)/
∑m
i=1 1(Gi = 1) and Ŷ (α0) is defined
analogously.
Hudgens and Halloran also proposed estimators of the variances of these estima-
tors. In particular, under (2.1) unbiased estimators for V ar{Ŷi(1,α1)|Gi = 1} and
V ar{Ŷ (1,α1)} are given by V̂ ar{Ŷi(1,α1)|Gi = 1} = (1− kiα1/ni)σˆ2i1(α1)/kiα1 where
σˆ2i1(α1) =
∑ni
j=1{yij(Zi)−Ŷi(1,α1)}2Zij/(kiα1−1) and V̂ ar{Ŷ (1,α1)}= (1−l/m)σˆ2g1(α1)
/l+∑mi=1(1−kiα1/ni)σˆ2i1(α1)Gi/(kiα1ml) where σˆ2g1(α1) =∑mi=1{Ŷi(1,α1)− Ŷ (1,α1)}2
Gi/(l−1). Hudgens and Halloran also proposed estimators of the variance of the various
causal effect estimators which are positively biased unless certain additivity conditions
hold. For example, if there exist constants η1, . . . ,ηm such that yij(1,αs) = yij(0,αs)+ηi
for all i= 1, . . . ,m and j = 1, . . . ,ni, then their estimator for the variance of D̂E(αs) is
unbiased; otherwise their estimator is positively biased. Similar additivity conditions
exist for the variance estimators of the other causal effect estimators.
2.3.2 Asymptotic Distributions
Below the asymptotic distributions of the causal effect estimators defined in Section
2.3.1 are derived. In Section 2.3.2.1, the setting where the numbers of individuals
per group n1, . . . ,nm grow large is considered. These results might be applicable, for
instance, when groups are defined to be all individuals in a particular geographic region.
For example, Sur et al. (2009) estimated the indirect, total, and overall effects of typhoid
vaccination in groups of people within contiguous geographic areas in India, where the
average group size was over 700. The results in Section 2.3.2.1 do not require the
number of groups to be large. On the other hand, in Section 2.3.2.2 we consider the
setting where the number of groups m grows large. These results do not require that
the number of individuals per group is large and could be applied, for instance, in
household based studies when the households (i.e., groups) are small but the number of
23
households in the study is large. For example, Millar et al. (2008) studied the indirect
effect of vaccination against pneumococcal disease in over 900 households containing
on average fewer than four individuals per household.
2.3.2.1 Large Groups
Propositions 1 – 3 below show that under certain conditions the group average
potential outcome estimators, group average direct effect estimator and the marginal
group average potential outcome estimators are asymptotically Normal (i.e., Gaussian).
The notation d−→N (0,1) will be used to denote convergence in distribution to a standard
Normal random variable.
Proposition 1. Let υij = yij(z,αs) and υi. = (υi1 + · · ·+υi,ni)/ni for z,s ∈ {0,1}. If
kiαs →∞,ni−kiαs →∞ (2.2)
and
max(υij−υi.)2∑ni
j=1(υij−υi.)2
max
{
ni−kiαs
kiαs
,
kiαs
ni−kiαs
}
→ 0 as ni→∞ (2.3)
where max(υij−υi.)2 = max{(υij−υi.)2 : j = 1, . . . ,ni}, then
Ŷi(z,αs)−yi(z,αs)√
V arαs{Ŷi(z,αs)}
∣∣∣∣∣∣Gi = s d−→N (0,1)
where V arαs{Ŷi(z,αs)}= V ar{Ŷi(z,αs)|Gi = s}.
Proposition 2. Assume (2.2) and that (2.3) holds for υij = yij(1,αs)/kiαs+yij(0,αs)/(ni−
kiαs). Then
D̂Ei(αs)−DEi(αs)√
V arαs{D̂Ei(αs)}
∣∣∣∣∣∣Gi = s d−→N (0,1)
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where V arαs{D̂Ei(αs)}= V ar{D̂Ei(αs)|Gi = s}.
Proposition 3. Assume(2.2) and that (2.3) holds for υij = yij(1,αs)−yij(0,αs). Then
Ŷi(αs)−yi(αs)√
V arαs{Ŷi(αs)}
∣∣∣∣∣∣Gi = s d−→N (0,1)
where V arαs{Ŷi(αs)}= V ar{Ŷi(αs)|Gi = s}.
Propositions 4.1 – 4.4 below show that, under certain conditions, the population
direct, indirect, total and overall effect estimators are asymptotically distributed as
a mixture of Normal random variables as the numbers of individuals per group grow
large, i.e., as nmin = min{n1, . . . ,nm} → ∞. Recall a random variable X follows a
finite Normal mixture distribution (McLachlan et al. 1988) if there exists a discrete
random variable U with support u1, . . . ,uh and parameter vectors µ = (µ(1), . . . ,µ(h))
and σ = (σ(1), . . . ,σ(h)) such that the density of X satisfies
fX(x) =
h∑
i=1
ω(i)f(x|µ(i),σ(i))
where ω(i) = Pr(U = ui) and f(x | µ(i),σ(i)) is the density of a Normal random variable
with mean µ(i) and standard deviation σ(i). Equivalently, (X −µ(i))/σ(i) | U = ui ∼
N (0,1) for i= 1, . . . ,h. Define a sequence of random variables {Xn} to have an asymp-
totically Normal mixture distribution if there exists a discrete random variable U with
support u1, . . . ,uh and sequences of parameter vectors {µn} and {σn} such that
Xn−µ(i)n
σ
(i)
n
∣∣∣∣ U = ui d−→N (0,1) as n→∞ (2.4)
for i= 1, . . . ,h, where µ(i)n and σ(i)n denote the ith components of µn and σn. When (2.4)
holds, for notational convenience we suppress the subscript n and write (X−µ)/σ d−→
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M(ω,h). The following proposition is stated in terms of α1; the analogous result holds
for α0.
Proposition 4.1. Assume (2.2) and that (2.3) holds for υij = yij(1,α1)/kiα1 +yij(0,α1)
/(ni−kiα1) for i = 1, . . . ,m. Assume for any simple random sample {i1, . . . , il} drawn
without replacement from {1, . . . ,m} that limV arα1{D̂Ei(α1)}/
∑
i∈{i1,...,il}
V arα1{D̂Ei(α1)}
as nmin→∞ exists for i∈ {i1, . . . , il}. Then for m<∞, D̂E(α1) has an asymptotically
Normal mixture distribution, i.e.,
D̂E(α1)−µDE
σDE
d−→M(ω,(ml ))
as nmin→∞. The parameter vectors, each of length
(
m
l
)
, are given by ω =
(
1/
(
m
l
))
,
µDE =
(
µ
(i1,...,il)
DE
)
and σDE =
(
σ
(i1,...,il)
DE
)
, where the elements of the vectors correspond
to all possible simple random sample {i1, . . . , il} without replacement from {1, . . . ,m},
with µ(i1,...,il)DE =
∑
i∈{i1,...,il}
DEi(α1)/l and σ(i1,...,il)DE =
[ ∑
i∈{i1,...,il}
V arα1{D̂Ei(α1)}
]1/2
/l.
Note in Proposition 4.1 and below the dependence of the parameters µDE and σDE
on αs and nmin are suppressed for notational convenience. From a single experiment
or trial, only one element from each of the vectors µDE and σDE is identifiable from
the observed data; in particular, only the parameters µi1,...,ilDE and σ
i1,...,il
DE are identi-
fiable where {i1, . . . , il} = {i ∈ {1, . . . ,m} :Gi = 1}. Hence the asymptotic distribution
of D̂E(α1) as the groups grow large is not identifiable without additional assumption-
s. One special case of Proposition 4.1 occurs when the groups are homogeneous in a
certain sense as described by the following corollary.
Corollary 1. If the assumptions of Proposition 4.1 hold and there exists µ(0)DE and σ
(0)
DE
such that µ(i1,...,il)DE = µ
(0)
DE and σ
(i1,...,il)
DE = σ
(0)
DE for all simple random samples {i1, . . . , il},
then µ(0)DE =DE(α1), σ
(0)
DE =
√
V ar{D̂E(α1)} and for m<∞,
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D̂E(α1)−DE(α1)√
V ar{D̂E(α1)}
d−→N (0,1) (2.5)
as nmin→∞.
Note that the condition µ(i1,...,il)DE = µ
(0)
DE and σ
(i1,...,il)
DE = σ
(0)
DE for all simple random
samples {i1, . . . , il} is equivalent to DE1(α1) = · · ·=DEm(α1) and V arα1{D̂E1(α1)}=
· · ·= V arα1{D̂Em(α1)}. In other words, if the group level direct effect estimators have
the same mean and variance, then (2.5) holds.
The next three propositions and corollaries give analogous results for the population
average indirect, total and overall effect estimators.
Proposition 4.2. Assume (2.2) and that (2.3) holds for υij = yij(0,αs), s = 0,1.
Assume for any simple random sample {i1, . . . , il} drawn without replacement from
{1, . . . ,m} that lim√
V arα1Ŷi(0,α1)/{lσ(i1,...,il)IE } exists for i ∈ {i1, ..., il} and lim
√
V arα1Ŷi(0,α1)/{(m−
l)σ(i1,...,il)IE } exists for i /∈ {i1, ..., il} as nmin→∞. Then for m<∞,
ÎE(α1,α0)−µIE
σIE
d−→M(ω,(ml ))
as nmin→∞. The parameter vectors, each of length
(
m
l
)
, are given by ω =
(
1/
(
m
l
))
,
µIE =
(
µ
(i1,...,il)
IE
)
, σIE =
(
σ
(i1,...,il)
IE
)
, where
µ
(i1,...,il)
IE =
∑
i∈{i1,...,il}
yi(0,α1)
l
− ∑
i/∈{i1,...,il}
yi(0,α0)
m− l
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σ
(i1,...,il)
IE =
 ∑
i∈{i1,...,il}
V arα1{Ŷi(0,α1)}
l2
+
∑
i/∈{i1,...,il}
V arα0{Ŷi(0,α0)}
(m− l)2

1
2
Corollary 2. If the assumptions of Proposition 4.2 hold and there exists µ(0)IE and σ
(0)
IE
such that µ(i1,...,il)IE = µ
(0)
IE and σ
(i1,...,il)
IE = σ
(0)
IE for all {i1, . . . , il}, then µ(0)IE = IE(α1,α0),
σ
(0)
IE =
√
V ar{ÎE(α1,α0)}, and for m<∞,
ÎE(α1,α0)− IE(α1,α0)√
V ar{ÎE(α1,α0)}
d−→N (0,1) (2.6)
as nmin→∞.
Proposition 4.3. Assume (2.2) and that (2.3) holds for υij = yij(z,αs), (z,s)∈{(1,1),(0,0)}.
Assume for any simple random sample {i1, . . . , il} drawn without replacement from
{1, . . . ,m} that lim
√
V arα1Ŷi(1,α1)/{lσ(i1,...,il)TE } exists for i∈{i1, ..., il} and lim
√
V arα1Ŷi(0,α1)/
{(m− l)σ(i1,...,il)TE } exists for i /∈ {i1, ..., il} as nmin→∞. Then for m<∞,
T̂E(α1,α0)−µTE
σTE
d−→M(ω,(ml ))
as nmin→∞. The parameter vectors, each of length
(
m
l
)
, are given by ω =
(
1/
(
m
l
))
,
µTE =
(
µ
(i1,...,il)
TE
)
, σTE =
(
σ
(i1,...,il)
TE
)
, where
µ
(i1,...,il)
TE =
∑
i∈{i1,...,il}
yi(1,α1)
l
− ∑
i/∈{i1,...,il}
yi(0,α0)
m− l
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σ
(i1,...,il)
TE =
 ∑
i∈{i1,...,il}
V arα1{Ŷi(1,α1)}
l2
+
∑
i/∈{i1,...,il}
V arα0{Ŷi(0,α0)}
(m− l)2

1
2
Corollary 3. If the assumptions of Proposition 4.3 hold and there exists µ(0)TE and σ
(0)
TE
such that µ(i1,...,il)TE = µ
(0)
TE and σ
(i1,...,il)
TE = σ
(0)
TE for all {i1, . . . , il}, then µ(0)TE = TE(α1,α0),
σ
(0)
TE =
√
V ar{T̂E(α1,α0)} and for m<∞,
T̂E(α1,α0)−TE(α1,α0)√
V ar{T̂E(α1,α0)}
d−→N (0,1) (2.7)
as nmin→∞.
Proposition 4.4. Assume (2.2) and that (2.3) holds for υij = yij(1,αs)−yij(0,αs), s=
0,1. Assume for any simple random sample {i1, . . . , il} drawn without replacement from
{1, . . . ,m} that lim
√
V arα1Ŷi(α1)/{lσ(i1,...,il)OE } exists for i∈{i1, ..., il} and lim
√
V arα1Ŷi(α1)/
{(m− l)σ(i1,...,il)OE } exists for i /∈ {i1, ..., il} as nmin→∞. Then for m<∞,
ÔE(α1,α0)−µOE
σOE
d−→M(ω,(ml ))
as nmin→∞. The parameter vectors, each of length
(
m
l
)
, are given by ω =
(
1/
(
m
l
))
,
µOE =
(
µ
(i1,...,il)
OE
)
, σOE =
(
σ
(i1,...,il)
OE
)
, where
µ
(i1,...,il)
OE =
∑
i∈{i1,...,il}
yi(α1)
l
− ∑
i/∈{i1,...,il}
yi(α0)
m− l
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σ
(i1,...,il)
OE =
 ∑
i∈{i1,...,il}
V arα1{Ŷi(α1)}
l2
+
∑
i/∈{i1,...,il}
V arα0{Ŷi(α0)}
(m− l)2

1
2
Corollary 4. If the assumptions of Proposition 4.4 hold and there exists µ(0)OE and
σ
(0)
OE such that µ
(i1,...,il)
OE = µ
(0)
OE and σ
(i1,...,il)
OE = σ
(0)
OE for all {i1, . . . , il}, then µ(0)OE =
OE(α1,α0), σ(0)OE =
√
V ar{ÔE(α1,α0)} and for m<∞,
ÔE(α1,α0)−OE(α1,α0)√
V ar{ÔE(α1,α0)}
d−→N (0,1) (2.8)
as nmin→∞.
2.3.2.2 Large Number of Groups
In this section the asymptotic distributions of the causal effect estimators are derived
when the number of groups m grows large, in particular when l→∞ and m− l→∞.
These results rely on the following Lindeberg condition (Lehmann 1998, eq. A.128):
Let {Wh} be a sequence of independent random variables, each having finite expected
value µh and variance σ2h. Define s2t =
∑t
h=1σ
2
h. If for every ε > 0
lim
t→∞
1
s2t
t∑
h=1
E
[
(Wh−µh)21{|Wh−µh|> εst}
]
= 0, (2.9)
then ∑th=1(Wh−µh)/st d−→ N (0,1) as t→∞. The propositions below indicate that,
under different versions of (11), the distributions of the causal effect estimators are
approximately Normal as m grows large. These results will have applicability in studies
with large numbers of groups even if the groups are small (e.g., households). Unlike
in Section 2.3.2.1, here the mean homogeneity assumption is not needed to justify the
Normal approximation.
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Proposition 5.1. Suppose for any simple random sample {i1, . . . , il} that (2.9) holds
for the sequence {Wh} defined by Wh = D̂Eih(α1)
∣∣∣Gi1 = · · ·=Gil = 1 for h= 1, . . . , l and
there exists σ(0)DE such that σ
(i1,...,il)
DE =σ
(0)
DE. Let υ˜i =DEi(α1) and υ˜. = (υ˜1+ . . .+ υ˜m)/m.
If limm→∞σ(0)DE/
√
V ar{D̂E(α1)} exists and
max(υ˜i− υ˜.)2∑m
i=1(υ˜i− υ˜.)2
max
{
m− l
l
,
l
m− l
}
→ 0 as m→∞ (2.10)
where max(υ˜i− υ˜.)2 = max{(υ˜i− υ˜.)2 : i= 1, . . . ,m}, then (2.5) holds as m→∞.
Proposition 5.2. Suppose for any simple random sample {i1, . . . , il} that (2.9) holds for
the sequence {Wh} defined by Wh =
{
Ŷih(0,α1)1(Gih = 1)/l− Ŷih(0,α0)1(Gih = 0)/(m−
l)
}∣∣∣Gi1 = · · ·=Gil = 1 for h= 1, . . . , l and there exists σ(0)IE such that σ(i1,...,il)IE = σ(0)IE . If
(2.10) holds for υ˜i = yi(0,α1)/l+yi(0,α0)/(m− l) and limm→∞σ(0)IE/√
V ar{ÎE(α1,α0)} exists, then (2.6) holds as m→∞.
Proposition 5.3. Suppose for any simple random sample {i1, . . . , il} that (2.9) holds for
the sequence {Wh} defined by Wh =
{
Ŷih(1,α1)1(Gih = 1)/l− Ŷih(0,α0)1(Gih = 0)/(m−
l)
}∣∣∣Gi1 = · · · = Gil = 1 for h = 1, . . . , l and there exists σ(0)TE such that σ(i1,...,il)TE = σ(0)TE.
If (2.10) holds for υ˜i = yi(1,α1)/l+yi(0,α0)/(m− l) and limm→∞σ(0)TE/√
V ar{T̂E(α1,α0)} exists, then (2.7) holds as m→∞.
Proposition 5.4. Suppose for any simple random sample {i1, . . . , il} that (2.9) holds
for the sequence {Wh} defined by Wh =
{
Ŷih(α1)1(Gih = 1)/l− Ŷih(α0)1(Gih = 0)/(m−
l)
}∣∣∣Gi1 = · · · = Gil = 1 for h = 1, . . . , l and there exists σ(0)OE such that σ(i1,...,il)OE = σ(0)OE.
If (2.10) holds for υ˜i = yi(α1)/l+yi(α0)/(m− l) and limm→∞σ(0)OE/
√
V ar{ÔE(α1,α0)}
exists, then (2.8) holds as m→∞.
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2.3.3 Confidence intervals and testing
2.3.3.1 Large sample approximations
The results in the previous two sections establish the limiting distributions of the d-
ifferent effect estimators when either the number of individuals per group or the number
of groups grows large. These results can be used to construct CIs when the limiting dis-
tribution is a single Normal. For example, under the conditions stated in the Corollary
to Proposition 4.1, we have {D̂E(α1)−DE(α1)}/
√
V ar{D̂E(α1)} d−→ N (0,1). Thus,
by Slutsky’s theorem, for γ ∈ (0,1) an asymptotic 1−γ CI of DE(α1) is
D̂E(α1)± z1−γ/2
√
V̂ ar{D̂E(α1)}
where z1−γ/2 is the 1−γ/2 quantile of the standard Normal distribution and V̂ ar{D̂E(α1)}
is a consistent estimator of V ar{D̂E(α1)}.
These CIs can be used in the large sample setting to test various null hypotheses
about the different treatment effects by examining whether the CI for a particular effect
contains the corresponding null value. Equivalently, test statistics can be constructed
to directly assess the null hypothesis of interest. For example, consider testing the
null hypothesis that the group level direct effects are all zero, i.e., H0 :DE1(α1) = . . .=
DEm(α1) = 0. Under the assumption that V arα1{D̂E1(α1)}= · · ·= V arα1{D̂Em(α1)},
the statistic T = D̂E(α1)/
√
V̂ ar{D̂E(α1)} will be approximately N (0,1) under H0,
provided either nmin or l is large.
The Wald CIs are applicable when the groups are homogeneous. Certain of these
homogeneity assumptions can be tested. For instance, the assumption that the direct ef-
fects are homogeneous across groups can be tested as follows. Suppose V arα1{D̂E1(α1)}=
· · · = V arα1{D̂Em(α1)} = σ2DE , where σ2DE is an unknown constant and the goal is
to test H0h : DE1(α1) = · · · = DEm(α1). Let T˜ = ∑mi=1{D̂Ei(α1)− D̂E(α1)}21(Gi =
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1)/σ̂2DE , where σ̂2DE is a consistent estimator for σ2DE . Then based on Proposition 2,
T˜ ∼ χ2l−1 under H0h as nmin→∞. Without further assumptions about the potential
outcomes, tests of mean homogeneity cannot be developed for indirect, total and overall
effects. To see this, consider the homogeneity assumptions given in the Corollary to
Proposition 4.2 that are sufficient for the indirect effect estimator to have a single Nor-
mal distribution asymptotically. The mean homogeneity assumption that there exists
µ
(0)
IE such that µ
(i1,...,il)
IE = µ
(0)
IE for all simple random samples {i1, . . . , il} is equivalent to
assuming y1(0,α1)+y1(0,α0) = · · ·= ym(0,α1)+ym(0,α0). Because only one element of
each pair {yi(0,α1),yi(0,α0)} is identifiable from the observable data, this assumption
is not subject to empirical test.
In the absence of homogeneity, the observed data do provide some information about
the asymptotic distributions such that inference relying on large sample approximations
may still be possible. For instance, CIs can be constructed using Chebyshev’s inequality.
For example, for the direct effect the interval D̂E(αs)±
√
V ar{D̂E(αs)}/γ will contain
DE(αs) with at least probability 1− γ. Because the Chebyshev inequality holds for
all distributions, such CIs are expected to often be conservative, i.e., have coverage
probability greater than 1−γ. In practice V ar{D̂E(αs)} will be unknown and can be
replaced with a consistent estimator V̂ ar{D̂E(αs)} which asymptotically will still give
a 1−γ CI.
2.3.3.2 Exact method
Rather than relying on large sample approximations, Tchetgen Tchetgen and Van-
derWeele (2012) derived exact CIs for various casual effects in the setting where the
outcome is binary based on the Hoeffding inequality. In particular, they showed under
two-stage permutation randomization that for any γ ∈ (0,1), the interval D̂E(α1)±
∗DE(γ,α1, q,m) is a (1−γ) CI of DE(α1), where
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∗DE(γ,α1, q,m) =
√√√√log(2/γ){4(1
q
−1
)2
+
m∑
i=1
LDE,i(α1)2
q2m
}
/(2m)
q = Pr(Gi = 1) = l/m and LDE,i(α1) = 2
{
1−1/
(
ni
kiα1
)}
for i = 1, . . . ,m. Similarly, the
interval ÎE(α1,α0)± ∗(γ,α1,α0, q,m) is a (1−γ) CI of IE(α1,α0), where
∗(γ,α1,α0, q,m) =
√√√√log(2/γ)[max{ 1
q2
,
1
(1− q)2
}
+
m∑
i=1
LIE,i(α1,α0, q)2/m
]
/(2m)
and LIE,i(α1,α0, q) = max
[{
1−1/
(
ni
kiα1
)}
/q,
{
1−1/
(
ni
kiα0
)}
/(1− q)
]
for i = 1, . . . ,m.
Likewise, exact (1−γ) CIs of TE(α1,α0) andOE(α1,α0) can be constructed by T̂E(α1,α0)
± ∗(γ,α1,α0, q,m) and ÔE(α1,α0)± ∗(γ,α1,α0, q,m) respectively. These CIs are ex-
act in the sense that the probability the interval contains the true parameter is at
least 1− γ for any m and n1, . . . ,nm. The exact CIs are appealing in that the only
assumptions required for the intervals to be valid are partial interference and two-stage
permutation randomization. However, in the simulation study in Section 2.4 below it
is demonstrated these CIs tend to be conservative, i.e., the exact CIs tend to be very
wide and cover the target parameter with probability greater than 1−γ. The form of
the exact CIs suggests several reasons why they are conservative. First, the widths of
the CIs are not data dependent, i.e., they do not depend on the observed outcomes
yij(Zi). Second, the widths of these CIs do not go to 0 as γ→ 1. Finally, for any given
data set and fixed γ, the widths of the CIs for the indirect, overall, and total effects
will be the same.
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2.4 Simulations
Simulations were conducted to verify the asymptotic distributions of the causal ef-
fect estimators derived in Sections 2.3.2.1 and 2.3.2.2 as well as to evaluate the finite
sample performance of the CIs described in Section 2.3.3. Simulations were conduct-
ed under four scenarios: (i) continuous outcomes with heterogeneity between groups,
(ii) continuous outcomes, homogeneous groups, (iii) binary outcomes, heterogeneous
groups, and (iv) binary outcomes, homogeneous groups. For scenario (i), the simula-
tion study was conducted in the following steps:
Step 1: A hypothetical population with m= 4 groups and n1 = · · ·= n4 = 1000 individu-
als within each group was created as follows. For i= 1, . . . ,4 and j = 1, . . . ,1000,
bij was randomly sampled from N (0,1). Then for zij = 0,1 and gi = 0,1
the potential outcomes for individual j in group i were set to yij(zij ,αgi) =
gi+0.7zij + bij + bijzij for i= 1,2 and yij(zij ,αgi) = gi+ bij + bijzij for i= 3,4.
Step 2: Groups were assigned α1 or α0 and individuals assigned z = 1 or z = 0 using
two-stage permutation randomization with l = 2, kiα1 = 500, and kiα0 = 200.
Step 3: The various causal effect estimators defined in Section 2.3.1 were calculated
based on the observed data from Step 2. The corresponding Wald and Cheby-
shev CIs as described in Section 2.3.3.1 were also computed, using the variance
estimators proposed by Hudgens and Halloran (2008).
Step 4: Steps 2 – 3 were repeated 5000 times.
Note the model used to generate the potential outcomes in Step 1 assumes partial and
stratified interference, such that under two-stage permutation randomization each indi-
vidual has four potential outcomes. The true causal effects for the simulated population
were DE(α1) = DE(α0) = 0.35, IE(α1,α0) = 1.00, TE(α1,α0) = 1.35, OE(α1,α0) =
1.10.
For these simulation n1 = · · ·= n4 = 1000, such that the asymptotic results for large
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groups derived in Section 2.3.2.1 apply. Figure 2.1 shows the accuracy of the Normal
mixture approximation to the distribution of the direct, indirect, total and overall
effect estimators. For simplicity, here and in the sequel results for D̂E(α0) are omitted.
The histograms give the empirical distributions of the estimators based on the 5000
simulated data sets. The solid lines, created using the R package nor1mix (Ma¨chler
2011), show the density of the Normal mixtures used to approximate the distributions
of the estimators. For the direct effect estimator the
(
m
l
)
=
(4
2
)
= 6 conditional means of
the Normal mixture were 0.71, 0.36, 0.35, 0.35, 0.34, -0.01. Because four of these means
are nearly identical, the approximate distribution of D̂E(α1) is trimodal (Figure 2.1
upper left panel). The distributions of the total and overall effect estimators are similar.
From the model in Step 1 above the simulated groups were approximately homogeneous
with respect to the indirect effect. For instance, the indirect effect conditional means
were 1.02, 1.01, 1.00, 1.00, 0.98 and 0.98. Thus, in accordance with the Corollary to
Proposition 4.2, the distribution of ÎE(α1,α0) for large groups is approximately Normal
(Figure 2.1 upper right panel).
Additional simulations were conducted under scenario (i) for various values of m
and n1 = · · · = nm. In each case we let l = m/2, kiα1 = 0.5ni, and kiα0 = 0.2ni, with
non-integer values rounded up to the nearest integer. Table 2.1 shows the empirical
coverage and width (i.e., average length) of the Wald and Chebyshev 95% CIs. Recall
that justification of the Wald CIs for small m requires certain mean homogeneity as-
sumptions as stated in the corollaries in Section 2.3.2.1. Therefore, because of the mean
heterogeneity between groups for the direct, total, and overall effects in scenario (i),
the Wald CIs were not necessarily expected to perform well for small m. Indeed, Table
2.1 shows the Wald CIs for these effects tend to under-cover for m≤ 10. These results
demonstrate the Wald CIs may not be particularly robust to violation of the mean
homogeneity assumption when m is small. On the other hand, the Wald CIs perform
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well for m ≥ 30, corroborating the results in Section 2.3.2.2. In contrast to the other
effects, the mean homogeneity assumption does approximately hold for the indirect
effect in scenario (i), suggesting that the corresponding Wald CIs should perform well
for small m provided ni is sufficiently large. To the contrary, the results in the bottom
of Table 2.1 show the Wald CIs of the indirect effect under-cover for ni = 1000 when
m is small. Further investigation revealed this under-coverage was attributable to the
estimated variance of the indirect effect estimator; when the true variance was used to
construct the Wald CIs, the coverage was approximately 95% (results not shown). The
Chebyshev CIs tended to perform better than the Wald CIs for small m, although for
ni = 1000 and m= 4 the Chebyshev CIs also under-covered due to using the estimated
variance. For m≥ 30 the Chebyshev CIs were overly conservative, with 100% coverage
for all effects for both ni = 6 and ni = 1000.
For scenario (ii), potential outcomes were simulated as above except in Step 1 we
let yij(zij ,αgi) = gi+ bij + bijzij for j = 1, . . . ,ni, i= 1, . . . ,m. Various values of m and
n1 = · · · = nm were considered for scenario (ii) as in scenario (i). In this scenario the
groups were approximately homogeneous; for example, the direct effectsDEi(α1) for i=
1, . . . ,m were all approximately 0 and the variances of the estimators V arα1{D̂Ei(α1)}
were all approximately the same. Table 2.2 gives the empirical coverage and width
of the Wald and Chebyshev CIs for scenario (ii). Results for the indirect effect are
identical to those in Table 2.1 because the same values were generated for yij(0,α0)
and yij(0,α1) in scenarios (i) and (ii). For the other effects, coverage for the Wald
CIs tends to be slightly better in Table 2.2 compared to Table 2.1 for small m and
large ni, but under-coverage persists despite mean homogeneity; this anti-conservative
performance of the Wald CIs can again be attributed to use of the estimated variances.
Coverage of the Chebyshev CIs was approximately 0.95 or greater for all effects and all
values of ni and m considered.
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For scenario (iii), simulations were conducted as in scenario (i) with m = 4 groups
each having ni = 1000 individuals but with the first step being replaced by the following:
Step 1: Of the 4000 individuals in the population, randomly assign 480 of the individuals
to have xij = 0, 480 of the individuals to have xij = 1, and the remaining
individuals to have xij = 2. If xij = 2, the potential outcomes were set to
yij(zij ,αgi) = gizij for i= 1,2 and yij(zij ,αgi) = gi(1−zij) for i= 3,4; otherwise
yij(zij ,αgi) = xij for i= 1, . . . ,4.
For this scenario there was heterogeneity between groups for the direct, indirect and
total effects. Similar to Figure 2.1 for scenario (i), the Normal mixture distributions
provided an excellent approximation to the empirical distributions of the estimators
(not shown). Simulations were also conducted under scenario (iii) for m= 6,10,30,100.
Because the outcomes in scenario (iii) were binary, for each simulated data set the exact
CIs described in Section 2.3.3.2 were computed in addition to the Wald and Chebyshev
CIs. Empirical coverage and width of the three types of CIs are given in Table 2.3.
Coverage of the Wald and Chebyshev CIs was similar to scenario (i), which also entailed
heterogeneous effects. The exact CIs were very conservative, with 100% coverage for
all effects and all values of m considered. Compared to the Wald and Chebyshev CIs,
the exact CIs tended to be as wide or wider, especially for the overall effect where the
exact CIs were at least an order of magnitude wider than the other CIs.
For scenario (iv), simulations were repeated as in scenario (iii) but the potential
outcomes were set to yij(zij ,αgi) = gizij if xij = 2 and yij(zij ,αgi) = xij otherwise. In
this scenario the groups were approximately homogeneous. Empirical coverage and
width of the three CIs are given in Table 2.4. For m≥ 30 the Wald CIs gave the correct
coverage and were the narrowest. For small m the Chebyshev and exact CIs both
provided at least 95% coverage, but the Chebyshev CIs were substantially narrower.
The widths of the exact CIs depend only on m,l,kiα1 ,kiα0 ,ni,γ and thus are the same
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for the simulations carried out in scenario (iii) and (iv). Coverage of the exact CIs was
always 100% in scenario (iv), as in scenario (iii).
In summary, the simulation results suggest for m ≥ 30 the Wald CIs tend to yield
nominal coverage levels while being narrower than the Chebyshev and exact CIs. For
m< 30 and continuous outcomes, the simulations suggest the Chebyshev CIs may be
preferred, although for m = 10 the Wald CIs tend to be narrower while still providing
approximately correct coverage. For m< 30 and binary outcomes, only the exact CIs
tend to provide the correct coverage when the effects are heterogeneous (scenario (iii)),
whereas the Chebyshev CIs tend to provide the correct coverage and are narrower than
the exact CIs when the effects are homogeneous (scenario (iv)).
2.5 Examples
2.5.1 Cholera Vaccine Trial
The indirect effects of vaccination have important public health implications. In an
analysis of data from an individually-randomized, placebo-controlled trial of two oral
cholera vaccines in Matlab, Bangladesh, Ali et al. (2005) found a significant association
between the level of vaccine coverage (i.e., the proportion of individuals vaccinated) and
the incidence of cholera in unvaccinated individuals, suggesting an indirect effect of the
vaccines. Motivated by the results given in Ali et al., Hudgens and Halloran (2008,
Table 2) provided data from a hypothetical two-stage randomized vaccine trial wherein
the first stage l = 3 of m = 5 geographically separate groups were randomly assigned
α1 and the other two groups α0, and in the second stage 50% of individuals in groups
assigned α1 were randomly assigned vaccine and 30% of individuals in groups assigned
α0 were randomly assigned vaccine. The number of individuals in the five groups
n1, . . . ,n5 ranged from roughly 19,000 to 36,000 such that the results from Section 3.2.1
apply.
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Table 2.5 gives point estimates and Wald, Chebyshev, and exact 95% CIs for the
different vaccine effects (cases of cholera per 1000 individuals per year) based on the
data from Hudgens and Halloran (2008) (see also VanderWeele and Tchetgen Tchetgen
(2011) for an analysis of these data). To obtain the results in Table 2.5 we let yij(Zi) = 1
if individual j in group i did not develop cholera and yij(Zi) = 0 otherwise, such that
positive values of the estimates reflect beneficial effects of the vaccine. For example,
D̂E(α1) indicates 1.30 fewer cases of cholera per 1000 person-years would be expected
among vaccinated individuals compared to unvaccinated individuals when vaccine cov-
erage is 50%. Wald CIs for the α0 direct effect, the total effect, and the overall effect all
exclude zero. However, the empirical results from Section 2.4 suggest Wald CIs should
be interpreted with caution when m= 5. The test for mean homogeneity of the direct
effect based on T˜ indicates significant heterogeneity for α1 (p = 0.01) but not for α0
(p= 0.54), providing additional reason to interpret the Wald CI for DE(α1) skeptically.
The Chebyshev CI for the α0 direct effect excludes zero, suggesting the risk of cholera is
significantly lower when vaccinated compared to when not vaccinated if the group level
coverage is low. The Chebyshev CI for the total effect also excludes zero. In contrast
to the Wald and Chebyshev CIs, the exact CIs are very wide and uninformative. As
pointed out by Tchetgen Tchetgen and VanderWeele (2012), the width of exact CI is
proportional to 1/
√
m and thus is expected to be wide when m is small.
2.5.2 Voting Encouragement Experiment
Assessing the indirect effects on an intervention is important in many areas beyond
public health, including econometrics and political science. Nickerson (2008) described
an experiment where households in Denver and Minneapolis with two registered voters
were randomly assigned to one of three conditions: (i) receive encouragement to vote;
(ii) receive encouragement to recycle; or (iii) receive nothing. Households assigned to
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(i) or (ii) were contacted one week prior to the 2002 primaries by canvassers knocking
on the households’ doors. In households where the door was answered, the canvassers
provided either voting or recycling encouragement to whichever individual of voting
age answered the door and recorded the name of that individual. Whether each reg-
istered member of the household subsequently voted in the 2002 primary was then
determined by voter turnout records. Nickerson found that individuals not directly
contacted by the canvassers tended to vote more often if the individuals belonged to
households assigned to voting encouragement compared to households assigned to re-
cycling encouragement. This suggests an indirect effect of the voting encouragement
intervention, which Nickerson referred to as a ‘secondary effect.’
For the analysis here we take the m = 392 households contacted in Minneapolis
(excluding one household where apparently both voters in the household were con-
tacted by canvassers) as the finite population of interest. Of these 392 households,
201 or 51.2% were randomly assigned to voting encouragement. The randomization
process by which these households were assigned to receive encouragement to vote or
recycle was complicated (see Nickerson (2005), (2008) for details); for simplicity we
assume each household was independently assigned to receive voting encouragemen-
t with probability 0.5. In the nomenclature of Tchetgen Tchetgen and VanderWeele
(2012), this corresponds to Bernoulli randomization at the group level. By design, at
the individual level exactly one (α1) or none (α0) of the ni = 2 registered voters in
each of the households received voting encouragement. Although the experimenters
did not randomly assign one of the two individuals in the household to receive the in-
tervention, for illustrative purposes assume among households assigned to α1 that each
individual received the intervention with equal probability. Under these assumptions,
Wald and Chebyshev CIs can be computed as described in Section 2.3.3.1, with slight
modifications owing to Bernoulli randomization at the group level (see the Appendix
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for details). Here we let yij(Zi) = 1 if individual j in group i voted in the election and
yij(Zi) = 0 otherwise, such that positive values of the effects indicate increased voter
turnout due to the encouragement intervention. Point estimates as well as Wald and
Chebyshev 90% CIs for the different voting encouragement effects are given in Table
2.5 (90% CIs were computed following Nickerson (2008), who interpreted p-values of
hypothesis tests for secondary effects at the γ = 0.1 level). The exact CIs were not
computed because permutation randomization was not employed at the group level.
The Wald CIs indicate the presence of indirect, total and overall effects. Based on a
similar result in the Denver experiment, Nickerson concluded the null hypothesis of
no indirect effect was unlikely. That is, there is likely interference between individuals
within the same household. The indirect effect estimate suggests that for every 100
households that receive the encouragement intervention, on average an additional eight
individuals will vote despite never coming into direct contact with a canvasser.
2.6 Discussion
In this paper, we consider inference about treatment effects when the population
consists of groups of individuals where interference is possible within groups but not
between groups. The asymptotic distributions of effect estimators were derived when
either the number of individuals per group or the number of groups grows large. Under
certain assumptions about homogeneity across groups, the asymptotic distributions
provide justification for Wald type CIs and tests. Empirical results suggest the Wald
CIs may be preferred provided there are a large number of groups; otherwise, for a
small number of groups, the Chebyshev CIs tend to provide correct coverage while
being narrower than the exact CIs.
The asymptotic distributions were derived under several key assumptions, such as
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partial and stratified interference. The partial interference assumption may be rea-
sonable when groups are sufficiently separated in space, in time, or socially. Methods
for assessing the stratified interference assumption are needed in future research, per-
haps building upon VanderWeele et al. (2012). The results in this paper also rely on
the assumption that certain two-stage randomization designs are employed to assign
groups to allocation strategies and individuals to treatment. Further research remains
to be conducted for other randomization designs and for observational studies where
interference may be present.
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2.7 Tables and Figures
Figure 2.1: Empirical distribution of various estimators
Empirical distribution of the direct effect DE(α1), indirect effect IE(α1,α0), total effect
TE(α1,α0) and overall effect OE(α1,α0) estimators forsimulations in scenario (i) with
m= 4 groups, ni = 1000 individuals per group, and continuous outcomes. The solid line
is the density of the approximating distribution.
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Table 2.1: Comparison among different CIs, continuous outcomes
Empirical width and coverage [in brackets] of Wald (W ) and Chebyshev (C) 95% CIs
of the direct effect DE(α1), indirect effect IE(α1,α0), total effect TE(α1,α0) and
overall effect OE(α1,α0) for simulations under scenario (i) with numbers of groups m,
number of individuals per group ni, and continuous outcomes.
m
4 6 10 30 100
ni = 6 DE(α1) W 3.70[0.88] 2.67[0.91] 2.03[0.93] 1.27[0.95] 0.73[0.95]
C 8.04[1.00] 5.92[1.00] 4.54[1.00] 2.88[1.00] 1.66[1.00]
IE(α1,α0) W 1.89[0.80] 1.60[0.87] 1.26[0.91] 0.88[0.93] 0.42[0.95]
C 3.92[0.94] 3.49[0.99] 2.82[1.00] 2.01[1.00] 0.96[1.00]
TE(α1,α0) W 3.79[0.76] 2.31[0.87] 2.32[0.91] 1.40[0.94] 0.74[0.96]
C 7.57[0.93] 4.95[0.98] 5.14[1.00] 3.17[1.00] 1.69[1.00]
OE(α1,α0) W 2.54[0.77] 1.44[0.88] 1.69[0.90] 1.04[0.94] 0.51[0.94]
C 5.46[0.94] 3.21[1.00] 3.83[1.00] 2.37[1.00] 1.17[1.00]
ni = 1000 DE(α1) W 0.86[0.66] 0.65[0.90] 0.50[0.90] 0.28[0.94] 0.15[0.95]
C 1.75[0.74] 1.44[0.91] 1.12[0.99] 0.63[1.00] 0.34[1.00]
IE(α1,α0) W 0.12[0.80] 0.10[0.88] 0.11[0.91] 0.06[0.94] 0.03[0.95]
C 0.24[0.95] 0.22[0.99] 0.25[1.00] 0.14[1.00] 0.08[1.00]
TE(α1,α0) W 1.21[0.66] 0.89[0.90] 0.69[0.97] 0.38[0.98] 0.20[0.99]
C 2.35[0.69] 1.95[0.90] 1.56[0.99] 0.87[1.00] 0.46[1.00]
OE(α1,α0) W 0.68[0.66] 0.48[0.90] 0.39[0.92] 0.21[0.96] 0.11[0.97]
C 1.31[0.66] 1.06[0.90] 0.88[0.99] 0.49[1.00] 0.26[1.00]
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Table 2.2: Comparison among different CIs, continuous outcomes (iii)
Empirical width and coverage [in brackets] of Wald (W ) and Chebyshev (C) 95% CIs
of the direct effect DE(α1), indirect effect IE(α1,α0), total effect TE(α1,α0) and
overall effect OE(α1,α0) for simulations under scenario (ii) with numbers of groups
m, number of individuals per group ni, and continuous outcomes.
m
4 6 10 30 100
ni = 6 DE(α1) W 3.51[0.89] 2.72[0.92] 1.92[0.94] 1.27[0.95] 0.71[0.95]
C 7.66[1.00] 6.05[1.00] 4.32[1.00] 2.87[1.00] 1.62[1.00]
IE(α1,α0) W 1.89[0.80] 1.60[0.87] 1.26[0.91] 0.88[0.93] 0.42[0.95]
C 3.92[0.94] 3.49[0.99] 2.82[1.00] 2.01[1.00] 0.96[1.00]
TE(α1,α0) W 3.14[0.78] 2.66[0.87] 2.06[0.91] 1.44[0.95] 0.70[0.95]
C 6.30[0.94] 5.73[0.98] 4.56[1.00] 3.25[1.00] 1.58[1.00]
OE(α1,α0) W 2.01[0.84] 1.81[0.88] 1.50[0.91] 1.09[0.95] 0.48[0.94]
C 4.38[0.97] 4.05[0.99] 3.40[1.00] 2.47[1.00] 1.10[1.00]
ni = 1000 DE(α1) W 0.27[0.93] 0.22[0.93] 0.18[0.94] 0.10[0.95] 0.06[0.95]
C 0.60[1.00] 0.49[1.00] 0.40[1.00] 0.23[1.00] 0.13[1.00]
IE(α1,α0) W 0.12[0.80] 0.10[0.88] 0.11[0.91] 0.06[0.94] 0.03[0.95]
C 0.24[0.95] 0.22[0.99] 0.25[1.00] 0.14[1.00] 0.08[1.00]
TE(α1,α0) W 0.21[0.78] 0.18[0.85] 0.19[0.91] 0.11[0.94] 0.06[0.95]
C 0.41[0.93] 0.37[0.98] 0.41[1.00] 0.24[1.00] 0.13[1.00]
OE(α1,α0) W 0.11[0.82] 0.10[0.88] 0.13[0.91] 0.07[0.93] 0.04[0.95]
C 0.23[0.96] 0.22[0.99] 0.30[1.00] 0.17[1.00] 0.09[1.00]
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Table 2.3: Comparison among different CIs, binary outcomes (iii)
Empirical width and coverage [in brackets] of Wald (W ), Chebyshev (C) and exact
(E) 95% CIs of the direct effect DE(α1), indirect effect IE(α1,α0), total effect
TE(α1,α0) and overall effect OE(α1,α0) for simulations under scenario (iii) with m
groups, ni = 1000 individuals per group, and binary outcomes.
m
4 6 10 30 100
DE(α1) W 1.73[0.67] 1.33[0.90] 0.99[0.79] 0.55[0.98] 0.30[0.93]
C 3.26[0.67] 2.89[0.90] 2.25[0.99] 1.26[1.00] 0.68[1.00]
E 6.07[1.00] 4.96[1.00] 3.84[1.00] 2.22[1.00] 1.21[1.00]
IE(α1,α0) W 1.22[0.67] 0.93[0.90] 0.70[0.99] 0.39[0.98] 0.21[0.99]
C 2.31[0.67] 2.02[0.90] 1.59[0.99] 0.89[1.00] 0.48[1.00]
E 3.84[1.00] 3.14[1.00] 2.43[1.00] 1.40[1.00] 0.77[1.00]
TE(α1,α0) W 1.22[0.67] 0.96[0.90] 0.70[0.99] 0.39[0.98] 0.21[0.99]
C 2.31[0.67] 2.08[0.90] 1.59[0.99] 0.90[1.00] 0.48[1.00]
E 3.84[1.00] 3.14[1.00] 2.43[1.00] 1.40[1.00] 0.77[1.00]
OE(α1,α0) W 0.03[0.85] 0.04[0.87] 0.02[0.92] 0.01[0.95] 0.01[0.96]
C 0.06[0.98] 0.09[1.00] 0.05[1.00] 0.03[1.00] 0.02[1.00]
E 3.84[1.00] 3.14[1.00] 2.43[1.00] 1.40[1.00] 0.77[1.00]
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Table 2.4: Comparison among different CIs, binary outcomes (iv)
Empirical width and coverage [in brackets] of Wald (W ), Chebyshev (C) and exact
(E) 95% CIs of the direct effect DE(α1), indirect effect IE(α1,α0), total effect
TE(α1,α0) and overall effect OE(α1,α0) for simulations under scenario (iv) with m
groups, ni = 1000 individuals per group, and binary outcomes.
m
4 6 10 30 100
DE(α1) W 0.06[0.94] 0.04[0.96] 0.03[0.97] 0.02[0.97] 0.01[0.97]
C 0.12[1.00] 0.09[1.00] 0.08[1.00] 0.05[1.00] 0.03[1.00]
E 6.07[1.00] 4.96[1.00] 3.84[1.00] 2.22[1.00] 1.21[1.00]
IE(α1,α0) W 0.04[0.80] 0.05[0.87] 0.03[0.90] 0.02[0.94] 0.01[0.94]
C 0.08[0.95] 0.10[0.99] 0.07[1.00] 0.04[1.00] 0.02[1.00]
E 3.84[1.00] 3.14[1.00] 2.43[1.00] 1.40[1.00] 0.77[1.00]
TE(α1,α0) W 0.04[0.87] 0.04[0.88] 0.03[0.93] 0.02[0.95] 0.01[0.98]
C 0.09[0.97] 0.10[0.99] 0.06[1.00] 0.04[1.00] 0.02[1.00]
E 3.84[1.00] 3.14[1.00] 2.43[1.00] 1.40[1.00] 0.77[1.00]
OE(α1,α0) W 0.03[0.85] 0.04[0.87] 0.02[0.92] 0.01[0.95] 0.01[0.96]
C 0.06[0.98] 0.09[1.00] 0.05[1.00] 0.03[1.00] 0.02[1.00]
E 3.84[1.00] 3.14[1.00] 2.43[1.00] 1.40[1.00] 0.77[1.00]
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Table 2.5: Data application
Wald (W ), Chebyshev (C) and exact (E) 1−γ CIs of the direct effect DE(αs),
indirect effect IE(α1,α0), total effect TE(α1,α0) and overall effect OE(α1,α0) for the
cholera vaccine trial described in Section 2.5.1 and the voting encouragement
experiment discussed in Section 2.5.2
Estimate W C E
Vaccine DE(α1) 1.30 [-0.52, 3.11] [-2.84, 5.43] [-3540, 3543]
Trial DE(α0) 3.64 [2.81, 4.46] [1.75, 5.52] [-2177, 2184]
γ = 0.05 IE(α1,α0) 2.81 [-0.63, 6.25] [-5.03, 10.7] [-2145, 2150]
TE(α1,α0) 4.11 [2.50, 5.71] [0.44, 7.77] [-2143, 2151]
OE(α1,α0) 2.37 [0.03, 4.71] [-2.98, 7.72] [-2145, 2150]
Voting DE(α1) 0.04 [-2.7e-3, 0.07] [-0.04, 0.11]
Experiment IE(α1,α0) 0.08 [0.01, 0.15] [-0.06, 0.22]
γ = 0.1 TE(α1,α0) 0.12 [0.04, 0.19] [-0.03, 0.26]
OE(α1,α0) 0.09 [0.02, 0.16] [-0.05, 0.22]
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Chapter 3
On Inverse Probability Weighted Estimators with Interference
3.1 Introduction
Typically in causal inference, each individual is assumed to have two potential
outcomes, one under treatment and one in the absence of treatment. This is part of
the stable unit treatment value assumption (Rubin 1980). Manski (2013) referred to
this as “individualistic treatment response” and viewed it as a restriction of the form
of treatment response function. However, the no interference assumption may not hold
in various settings. For instance, in infectious disease studies, the vaccination status
of one individual may affect whether another individual becomes infected (Halloran
and Struchiner 1995). Nickerson (2008) described a voting encouragement study where
encouraging individuals to vote increased the likelihood another individual in the same
household would vote.
Recently methods have been developed for the setting where individuals can be
partitioned into groups such that there may be interference between individuals in the
same group but not between individuals in different groups. This is called “partial in-
terferenceąś (Sobel 2006). Assuming partial interference, Hudgens and Halloran (2008)
defined the direct, indirect (or spillover), total, and overall causal effects of an interven-
tion. For observational settings where treatment is not randomly assigned, Tchetgen
Tchetgen and VanderWeele (2012) proposed inverse probability weighted (IPW) esti-
mators of these causal effects. These IPW estimators are unbiased when the propensity
scores are known and can be viewed as a generalization of the usual IPW estimator
of the causal effect of a treatment in the absence of interference. However, in general,
IPW estimators are known to have relatively large variance. One possible remedy is
to replace the sample size with its estimate in the IPW estimators. The modified esti-
mator is known as a Hajek ratio estimator. Here, we consider the situation where any
interference structure is possible and develop Hajek type estimators for various causal
effects.
3.2 Notations, Assumptions and Estimands
Consider a population of n individuals. For individual i = 1, . . . ,n, let Zi be the
random variable of the received treatment, where Zi = 1 denotes individual i received
treatment and Zi = 0 if she received control. Define the interference set Xi for indi-
vidual i to be all other individuals such that their treatment received might affect the
outcome of individual i. Let Si = {Zj : j ∈Xi} denote the set of treatment indicators for
individuals that possible interfere with individual i. That is, the outcome of individual
i is allowed to depend not only on Zi but also on Si. For example, if the outcome of
individual 1 possibly depends on her own treatment status as well as that of individual
2 and 3, then, X1 = {2,3} and S1 = {Z2,Z3}. Let yi(zi, si) denote the potential outcome
of individual i if she received treatment zi and her interference group received si. Note
that the potential outcome notation introduced here is general enough to encompass
any possible interference structure of which the partial inference assumption is a spe-
cial case. Let Yi = yi(Zi,Si) denote the observed outcome. Let Li denote the random
vector of pre-treatment covariates of individual i. Let Z = {Z1, . . . ,Zn} denote the
random vector of treatment for the entire population and let L = {L1, . . . ,Ln} denote
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pre-treatment covariates for the entire population. Let zi, si and z be possible values
that Zi, Si, Z can take. Let
∑
Si be the sum over all the elements in Si and |Si| be the
length of the vector. For example, if S1 = {Z2,Z3} then ∑S1 = Z2 +Z3 and |S1|= 2.
For ease of exposition, we use “allocation strategy αk” to denote the treatment as-
signment where each individual is independently assigned treatment with probability
αk. Let pi(Si;αk) = α
∑
Si
k (1−αk)|Si|−
∑
Si denote the probability of the interference
set being assigned treatment Si. Let pi(Zi;αk) = αZik (1−αk)1−Zi and pi(Zi,Si;αk) =
pi(Zi;αk)pi(Si;αk) denote respectively the probability of individual i being assigned
treatment Zi and the probability of individual i together with their interference set be-
ing randomly assigned joint treatment (Zi,Si). Define yi(z,αk) =
∑
si yi(zi = z,si)pi(si;αk)
to be the average potential outcome for individual i under allocation strategy αk. Re-
turning to the example where S1 = {Z2,Z3}, the average potential outcome of individual
1 is a weighted average of outcome under different combination of treatment Z1 = z and
(Z2,Z3)∈ {(0,0),(0,1),(1,0),(1,1)}. Averaging over all the individuals in the study, de-
fine the population average potential outcome as y(z,αk) =
∑n
i=1 yi(z,αk)/n. Similarly
define the marginal average potential outcome for individual i under allocation strategy
αk by yi(αk) =
∑
zi,si yi(zi, si)pii(zi, si;αk) and define the population marginal average
potential outcome as y(αk) =
∑n
i=1 yi(αk)/n.
Define the direct effect of a treatment under allocation strategy αk to be DE(αk) =
g{y(1,αk),y(0,αk)} for k = 0,1, where g(·, ·) is some continuous contrast function. For
example, a commonly used contrast function is g(x1,x2) = x1−x2 and in vaccine tri-
als it is typical to use g(x1,x2) = 1− x2/x1, which can be interpreted as proportion
reduction in risk for a binary outcome. The direct effect measures the contrast of av-
erage potential outcomes on an individual when applying the treatment directly under
allocation strategy αk. Let IE(α1,α0) = g{y(0,α1),y(0,α0)} be the indirect effect and
let TE(α1,α0) = g{y(1,α1),y(0,α0)} be the total effect. The indirect effect measures
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the contrast between average potential outcomes of individuals who have the same
treatment but under different treatment allocation strategy. Note indirect can also be
defined for individuals who receives treatment z = 1, for simplicity, we do not con-
sider such indirect effect here. The total effect incorporates both direct and indirect
effects, and reflects the difference between the potential outcomes for individuals with
treatment under one allocation strategy compared to without treatment under another
allocation strategy. Finally, define OE(α1,α0) = g{y(α1),y(α0)} to be the overall ef-
fect. The overall effect may be the most relevant for policy making since it describes
the difference in outcomes under one allocation strategy relative to another strategy.
Define f(Z|L) = Pr(Z|L) to be the propensity score. We assume that conditional on
covariates L, the probability of any treatment z is non-zero, i.e., f(Z = z|L= l)> 0 for
all z and l. We also assume that conditional on covariates L, the treatment allocation
is independent of the outcome y(·), that is f(Z|L) = f(Z|L,y1(·), . . . ,yn(·)). We make
these two assumptions throughout.
3.3 IPW and Hajek-type Estimators
In this section, we first propose IPW and stablized estimators for y(z,αk) and y(αk)
under a completely general interference structure when the propensity scores are known.
The stablized estimators are generalizations of Hajek estimators in survey sampling
literature. Then we discuss their properties including unbiasedness, consistency and
asymptotic Normality. In §3.3.2, we propose estimators when the propensity scores
are unknown but correctly modeled and derive the asymptotic Normality under such
scenario. In §3.3.3, the IPW and Hajek estimators for the direct, indirect, total, and
overall effects are proposed and their the asymptotic properties are derived under both
the scenarios where the propensity scores are known or unknown.
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3.3.1 Known Propensity
Define the IPW estimator for treatment z under allocation strategy αk to be
Ŷ ipw(z,αk) = n−1
n∑
i=1
yi(Zi,Si)1(Zi = z)pi(Si;αk)
f(Zi,Si|Li) (3.1)
and define the IPW marginal estimator under allocation strategy αk to be
Ŷ ipw(αk) = n−1
n∑
i=1
yi(Zi,Si)pi(Zi,Si;αk)
f(Zi,Si|Li) (3.2)
where f(Zi,Si|Li) = ∫ f(Z|Li)dZ˜i and the integral is taken over Z˜i =Z/(Zi,Si) which is
the treatment of all individuals other than individual i and those in the interference set
of i. Tchetgen Tchetgen and VanderWeele (2012) proposed an IPW estimator when the
partial interference assumption holds. When the interference set of each individual is
assumed to be the treatment vector of individuals in the same group and if the groups
are of the same size, then the IPW estimator defined here is the same as the IPW
estimator proposed by Tchetgen Tchetgen and VanderWeele. If f(Zi,Si|Li) is known
for all i, Ŷ ipw(z,αk) is an unbiased estimator for y(z,αk) and Ŷ ipw(αk) is unbiased for
y(αk) as shown in the following Proposition.
Proposition 1. E{Ŷ ipw(z,αk)}= y(z,αk) and E{Ŷ ipw(αk)}= y(αk)
It is well known that IPW estimators have large variance (Sa¨rndal et al. 2003
chap. 5.7) and thus may lead to imprecise inferences when the sample size is small.
One possible remedy is to replace the population size with an estimator of n. The
classic Hajek estimator (Ha´jek 1971) when there is no interference uses the marginal
distribution f(Zi|Li) to estimate n. That is, nˆ1,z =∑ni=1 1(Zi = z)/f(Zi|Li), and it is
easy to see that E{nˆ1,z} = n. In the presence of interference, E{nˆ1,z} = n still holds,
thus, by replacing n with nˆ1,z in (3.1) and (3.2) one can get a Hajek type of estimator
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in the presence of interference. Alternatively, notice the inverse weights in the IPW
estimators defined previously, involve the joint distribution f(Zi,Si|Li) which suggests
the use of the joint distribution in constructing the estimate for population size n. Let
nˆ2,z =
∑n
i=1 1(Zi = z)pi(Si;αk)/f(Zi,Si|Li) and we have E{nˆ2,z}= n. Define the Hajek
estimators of the population average outcome of treatment z with allocation strategy
αk to be
Ŷ hajh (z,αk) = nˆ
−1
h,z
n∑
i=1
yi(Zi,Si)1(Zi = z)pi(Si;αk)
f(Zi,Si|Li) (3.3)
Let nˆ1 =
∑n
i=1pi(Zi;αk)/f(Zi|Li) and nˆ2 =
∑n
i=1pi(Zi,Si;αk)/f(Zi,Si|Li) then E{nˆh}=
n for h = 1,2. Define the population marginal outcome with allocation strategy αk to
be
Ŷ hajh (αk) = nˆ
−1
h
n∑
i=1
yi(Zi,Si)pi(Zi,Si;αk)
f(Zi,Si|Li) (3.4)
for k = 0,1 and h = 1,2. Note both nˆh,z and nˆh depend on αk, but we suppress this
dependence for notational convenience. We call Ŷ haj1 (·) and Ŷ haj2 (·) “Hajek 1ąś and
“Hajek 2ąś estimator respectively.
An appealing property of Ŷ haj2 (z,αk) and Ŷ
haj
2 (αk) is the preservation of the bounds
of the potential outcome yi(·). Specifically, suppose there exists Ml ≤Mu such that
Ml ≤ yi(·) ≤Mu for i = 1, . . . ,n; then one can show that Ml ≤ Ŷ haj2 (z,αk) ≤Mu and
Ml ≤ Ŷ haj2 (αk)≤Mu. For example, if yi(·) is binary, then Ŷ haj2 (z,αk), Ŷ haj2 (αk)∈ [0, 1].
In contrast, this is not guaranteed for Ŷ ipw(·) or Ŷ haj1 (·).
Another property of Ŷ haj2 (z,αk) and Ŷ
haj
2 (αk) is that a linear transformation on the
outcome y will result in the same linear transformation on Ŷ haj2 (z,αk) and Ŷ
haj
2 (αk).
Let Ŷ (·;y) denote the dependence of an estimator Ŷ on the outcome y. Then for
a linear transformation L(x) = ax+ b, we have Ŷ haj2 (·;L(y)) = L(Ŷ haj2 (·;y)) for any
a,b ∈R. This property indicates that a linear transformation on the coding of y (e.g.,
55
centering or scaling) results in the same linear transformation on the Hajek 2 estimator.
This relationship holds for the IPW and Hajek 1 estimator only when b = 0. One
ramification of this property will become evident when we consider the different causal
effect estimators in §3.3.3 below.
The Hajek-type of estimator is not unbiased in general. However, noting that
Ŷ hajh (z;αk) = Ŷ ipw(z;αk)n/nˆh,z, it follows from Sa¨rndal et al. (2003) p. 176 §5.6
that
|E{Ŷ hajh (z;αk)}−y(z;αk)|√
V ar{Ŷ hajh (z;αk)}
≤ n−1
√
V ar{nˆh,z}
Thus, if V ar{nˆh,z}= o(n2), then bias ratio |E{Ŷ hajh (z;αk)}−y(z;αk)|/
√
V ar{Ŷ hajh (z;αk)}
goes to 0 as n→∞. Note V ar{nˆ1,z}=∑ni,i′=1{fi,i′ −fifi′}/{fifi′} where fi = f(Zi =
z|L) and fi,i′ = f(Zi = z,Zi′ = z|L). Thus, if conditional on covariates L, the treat-
ment allocation is independent between individuals with probability f(Zi = z|L) for
individual i then V ar{nˆ1}=∑ni=1{1−f(Zi = z|L)}=O(n) and thus is also o(n2). The
formulas of V ar{nˆ2,z} and V ar{nˆ2} are more complicated and involve higher order
moments of the joint treatment allocation probability.
Using Taylor linearization, one can compare the asymptotic variance for Ŷ hajh (z;αk)
and Ŷ ipw(z;αk). Define Ŷ hajh,0 (z;αk) to be the first order Taylor expansion of Ŷ
haj
h (z;αk) =
Ŷ ipw(z;αk)n/nˆh,z at y(a;αk) and n for Ŷ ipw(z;αk) and nˆh,z respectively, then Ŷ hajh,0 (z;αk) =
y(z;αk) + Ŷ ipw(z;αk)− y(z;αk)nˆh,z/n. Thus V ar{Ŷ hajh,0 (z;αk)} = V ar{Ŷ ipwi (z;αk)}+
y2(z;αk)V ar(nˆh,z/n)−2y(z;αk)Cov{Ŷ ipw(z;αk), nˆh,z/n}. For random variable X, de-
fine CV (X) =
√
V arX/EX to be the coefficient of variation of X. Suppose CV (nˆh,z)/
CV {Ŷ ipw(z,αk)}≤ 2Corr{nˆh,z, Ŷ ipw(z,αk)} then V ar{Ŷ hajh,0 (z;αk)}≤V ar{Ŷ ipw(z;αk)}.
In the extreme case, if CV (nˆh,z)/CV {Ŷ ipw(z,αk)} = 2Corr{nˆh,z, Ŷ ipw(z,αk)} then
V ar{Ŷ hajh,0 (z;αk)}= V ar{Ŷ ipw(z;αk)}−y2(z;αk)V ar{n̂h,z/n}.
For simplification, we make the following assumptions when we derive the asymp-
totic distribution of the IPW and Hajek estimators.
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Assumption 1. There exists a partition {Cv}mv=1 of {1, . . . ,n} such that i /∈ Xi′ for
any i ∈ Cv, i′ ∈ Cv′ and v 6= v
′ for m ∈N .
Assumption 2. Suppose f(Z1, . . . ,Zn|L) =∏mv=1 f({Zi : i∈Cv}|L) and that f(Zi,Si|L)
is the same for all i ∈ Cv.
Assumption 1 is the partial interference assumption, i.e., the study population can
be partitioned into clusters and individuals in same cluster may interfere with each
other. Assumption 2 conjectures that the treatment selection has “cliqueąś structure,
i.e., dependence of treatment selection exists within cluster not across and interference
within clusters is symmetric in the sense that the propensity scores are the same for
individuals in the same cluster. Additionally, we assume clusters are i.i.d.. The fol-
lowing proposition shows the asymptotic Normality of Ŷ ipw(z,αk) and Ŷ hajh (z,αk), the
proofs of which are provided in the Appendix. For notational convenience, we write
Ŷ ipwi (z,αk) = yi(Zi,Si)1(Zi = z)pi(Si;αk)/f(Zi,Si|Li) and we suppress the dependence
of variance for IPW and Hajek estimators on z and αk when there is no confusion. For
the rest of the paper, assume that m=O(n) and m 6= o(n).
Proposition 2. If the propensity scores are known and Assumptions 1 and 2 hold, then
as n→∞,
(a)
√
n{Ŷ ipw(z,αk)− y(z,αk)}/σipw d−→ N(0,1), where σipw =
√
m∑
v=1
Eψ2v/n, ψv =
ψipwv (z,αk) =
∑
i∈Cv
{Ŷ ipwi (z,αk)−yi(z,αk)};
(b)
√
n{Ŷ haj1 (z,αk)− y(z,αk)}/σhaj1 d−→ N(0,1), where σhaj1 =
√
m∑
v=1
Eψ2v/n, ψv =
ψhaj1,v (z,αk) =
∑
i∈Cv
{Ŷ ipwi (z,αk)−yi(z,αk)pi(Z;αk)/f(Zi|Li)}−{yi(z,αk)−y(z,αk)};
(c)
√
n{Ŷ haj2 (z,αk)− y(z,αk)}/σhaj2 d−→ N(0,1), where σhaj2 =
√
m∑
v=1
Eψ2v/n, ψv =
ψhaj2,v (z,αk) =
∑
i∈Cv
{Ŷ ipwi (z,αk)−yi(z,αk)1(Zi = z)pi(Si;αk)/f(Zi,Si|Li)}−{yi(z,αk)−
y(z,αk)};
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Note if y1(z,αk) = · · ·= yn(z,αk), then a consistent estimator for (σipw)2 is (σˆipw)2 =∑m
v=1 ψˆ
2
v/n, where ψˆv =
∑
i∈Cv{Ŷ ipwi (z,αk)− Ŷ ipw(z,αk)}. Similarly, a consistent es-
timator for (σhaj1 )2 is (σˆ
haj
1 )2 =
∑m
v=1 ψˆ
2
v/n, where ψˆv =
∑
i∈Cv{Ŷ ipwi (z,αk)− Ŷ haj1 (z,αk)
1(Zi = z)/f(Zi|Li)} and for (σhaj2 )2 is (σˆhaj2 )2 =
∑m
v=1 ψˆ
2
v/n, where ψˆv =
∑
i∈Cv{Ŷ ipwi (z,αk)
− Ŷ haj2 (z,αk)1(Zi = z)pi(Si;αk)/f(Zi,Si|Li)}.
3.3.2 Unknown Propensity
All of the above results assume the propensity scores f(Zi|Li) or f(Zi,Si|Li) are
known. We now generate these results when the propensity score is not known but
can be consistently estimated. The IPW and Hajek estimators are defined similarly
as in (3.1)-(3.4) except that the propensity scores f(Zi|Li) and f(Zi,Si|Li) are re-
placed by their estimates fˆ(Zi|Li) and fˆ(Zi,Si|Li). For simplicity, we only discuss the
case where we have partial interference. Similar results and derivations hold in the
more general situation (given in the Appendix). Routinely, one would fit a parametric
model for the propensity scores, e.g., a logistic regression with a random effect adjust-
ing for the correlation within same clusters, and thus estimate the propensity scores
by maximum likelihood. The log likelihood function l(γ,σ2b ) =
∑m
v=1 lv(γ,σ2b ), where
lv(γ,σ2b ) = logf(Zi,Si|Li) for i ∈ Cv, and the maximum likelihood estimators of γ and
σ2b are solutions to the estimating equations ∂l(γ,σ2b )/∂γ= 0 and ∂l(γ,σ2b )/∂σ2b = 0. The
next proposition (under some additional regularity conditions) establishes the asymp-
totic Normality of Yˆ ipw(z,αk) and for its normalized variance we have (σipw∗ (z,αk))2 =
V ar{√nYˆ ipw(z,αk)} ≤ (σipw(z,αk))2, which is a well known result in the absence of
interference. This relationship in variance when the propensity scores are known com-
pared to unknown but correctly modeled also holds for the Hajek 2 estimators but not
necessarily for Hajek 1 estimators.
Proposition 3. If Assumptions 1 and 2 hold, then as n→∞
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(a)
√
n{Yˆ ipw(z,αk)−y(z,αk)}/σipw∗ d−→N(0,1), where (σipw∗ )2 = (σipw)2−HipwTV −1γ,σ2bH
ipw,
Hipw =∑mv=1 |Cv|EYˆ ipwv (z,αk)∂lv/n and Vγ,σ2b =∑mv=1E∂lTv ∂lv/n.
(b)
√
n{Yˆ haj1 (z,αk)−y(z,αk)}/σhaj1,∗ d−→N(0,1), where (σhaj1,∗ )2 = (σhaj1 )2+2ATV −1γ,σ2bH
haj
1 +
Hhaj1
T
V −1
γ,σ2b
Hhaj1 , where A=
∑m
v=1Eψ
haj
1,v ∂l
T
v /n and H
haj
1 =
∑m
v=1E∂ψ
haj
1,v
T
/n.
(c)
√
n{Yˆ haj2 (z,αk)−y(z,αk)}/σhaj2,∗ d−→N(0,1), where (σhaj2,∗ )2 = (σhaj2 )2−Hhaj2
T
V −1
γ,σ2b
Hhaj2
and Hhaj2 =
∑m
v=1Eψ
haj
2,v ∂l
T
v /n.
If y1(z,αk) = · · ·= yn(z,αk), a consistent estimator for (σipw∗ )2 is given by (σˆipw∗ )2 =
(σˆipw)2−HˆipwT Vˆ −1
γ,σ2b
Hˆipw, where Hˆipw =
m∑
v=1
|Cv|Yˆ ipwv (z,αk)∂ˆlTv /n, Vˆγ,σ2b =
∑m
v=1 ∂ˆl
T
v ∂ˆlv/n
and ∂ˆlv(γ,σ2b ) = ∂lv(γˆ, σˆ2b ). A consistent estimator for H
haj
1 is Hˆ
haj
1 =−
∑m
v=1 |Cv|∂ˆlTv
Yˆ ipwv (z,αk)/n+ Ŷ
haj
1 (z,αk)
∑n
i=1pi(Zi;αk)∂ˆ logf(Zi|Li)T /n where ∂ˆ logf(Zi|Li) = ∂ log
f(Zi|Li)|f=fˆ . And a consistent estimator for Hhaj2 is Hˆhaj2 =−
∑m
v=1 |Cv|{Yˆ ipwv (z,αk)−
Ŷ haj2 (z,αk)1(Zi = z)pi(Si;αk)/fˆ(Zi,Si|Li)}∂ˆlv/n. Thus, one can construct a consistent
estimator for (σhaj1,∗ )2 and (σ
haj
2,∗ )2.
For example, the propensity score can be estimated by a mixed effects logistic
regression model:
log{ei/(1− ei)}= Liγ+ bv (3.5)
where ei = f(Zi = 1|Li, bv) for i ∈ Cv and bv i.i.d ∼N(0,σ2b ). The variance of the IPW
and Hajek estimators and their variance estimators are given in the Appendix.
3.3.3 Causal Effect Estimators
In this section, we first give the results of IPW and Hajek causal effect estima-
tors assuming the propensity scores are known. Then their counterparts are given
when the propensity scores are unknown but correctly modeled. Define D̂Eipw(αk) =
g{Ŷ ipw(1,αk), Ŷ ipw(0,αk)} to be the IPW estimator for the direct effect. Also define
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ÎE
ipw(α1,α0) = g{Ŷ ipw(0,α1), Ŷ ipw(0,α0)}, T̂Eipw(α1,α0) = g{Ŷ ipw(1,α1), Ŷ ipw(0,α0)}
and ÔEipw(α1,α0) = g{Ŷ ipw(α1), Ŷ ipw(α0)} to be the indirect, total and overall effect
IPW estimators. Hajek-type causal effect estimators can be defined similarly. For ex-
ample define the Hajek-type of direct effect estimator to be D̂Ehajh (αk) = g(Ŷ
haj
h (1,αk),
Ŷ hajh (0,αk)). If the contrast function g(x1,x2) is linear in x1 and x2, then the IPW
causal effect estimators are all unbiased estimators for the corresponding causal effects
and both types of Hajek estimators are asymptotically unbiased.
Recall that the Hajek 2 estimators defined in §3.3.1 and §3.3.2 preserve linear trans-
formation on the outcome. Further, if the contrast function g(x1,x2) = x1−x2 and then
the absolute value of Hajek 2 causal effects estimators are invariant under location shift.
For example, for the direct effect we have D̂Ehaj2 (αk;y+ c) = D̂E
haj
2 (αk;y). Further
note that for the binary outcome y, we have D̂Ehaj2 (αk;1− y) = −D̂E
haj
2 (αk;y). The
same relationship holds for other Hajek 2 causal effect estimators. That is, for binary
outcome, the coding of the outcome will only change the sign of the causal effect estima-
tors but not the magnitude. This is not the case for IPW and the Hajek 1 causal effect
estimators; how the sign and the magnitude will change depends on the propensity
scores as well.
The results for average mean outcome estimators in §3.3.1 and §3.3.2 can be gen-
eralized to causal effect estimators. Let 5g = (∂g/∂x1,∂g/∂x2) denote the gradient of
function g. For the direct effect, we have
Proposition 4. If the propensity score is known and Assumptions 1 and 2 hold then
as n→∞
(a)
√
n{D̂Eipw(αk)−DE(αk)}/σD,ipw d−→N(0,1), where σD,ipw =
√
m∑
v=1
Eψ2v/n and
ψv = ψD,ipwv (αk) =5g(ψipwv (1,αk),ψipwv (0,αk))T ;
(b)
√
n{D̂Ehaj1 (αk)−DE(αk)}/σD,haj1 d−→N(0,1), where σD,haj1 =
√
m∑
v=1
Eψ2v/n and
ψv = ψD,haj1,v (αk) =5g(ψhaj1,v (1,αk),ψhaj1,v (0,αk))T ;
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(c)
√
n{D̂Ehaj2 (αk)−DE(αk)}/σD,haj2 d−→N(0,1), where σD,haj2 =
√
m∑
v=1
Eψ2v/n and
ψv = ψD,haj2,v (αk) =5g(ψhaj2,v (1,αk),ψhaj2,v (0,αk))T ;
And when the propensity scores are unknown we have:
Proposition 5. If Assumptions 1 and 2 hold, then as n→∞
(a)
√
n{D̂Eipwv (αk)−DE(αk)}/σipw∗ d−→N(0,1), where (σD,ipw∗ )2 = (σD,ipw)2−
HD,ipw
T
V −1
γ,σ2b
HD,ipw, HD,ipw =∑mv=1EψD,ipwv (αk)∂lv/n and Vγ,σ2b =∑mv=1E∂lTv ∂lv/n
(b)
√
n{D̂Ehaj1 (αk)−DE(αk)}/σD,haj1,∗ d−→ N(0,1), where (σD,haj1,∗ )2 = (σD,haj1 )2 +
2ATV −1
γ,σ2b
HD,haj1 +H
D,haj
1
T
V −1
γ,σ2b
HD,haj1 , where A=
∑m
v=1Eψ
D,haj
1,v (αk)∂lTv /n and H
D,haj
1
=∑mv=1E∂ψD,haj1,v (αk)/n
(c)
√
n{D̂Ehaj2 (αk)−DE(αk)}/σD,haj2,∗ d−→ N(0,1), where (σD,haj2,∗ )2 = (σD,haj2 )2 −
HD,haj2
T
V −1
γ,σ2b
HD,haj2 and H
D,haj
2 =
∑m
v=1Eψ
D,haj
2,v (αk)∂lv/n.
The results can be derived similarly for indirect, total and overall effects estimators.
3.4 Simulation Study
A simulation study was conducted to investigate the bias, empirical square error
(ESE) and average estimated square error (ASE) of the different estimators discussed in
§3.3. Thus, in the simulations, Ŷ ipw(z,α0), Ŷ haj1 (z,α0) and Ŷ haj2 (z,α0) were computed
with the (i) known propensity score, (ii) estimated by a correct model and (iii) estimated
by a misspecified model. Simulations were conducted for both continuous and binary
outcomes. Let dae denote the smallest integer greater than or equal to a and let bac
denote the largest integer smaller than or equal to a. The simulation study for a
continuous outcome was carried out in the following steps:
Step 1: A hypothetical population with n = 2000 individuals was created as follows.
For i = 1, . . . ,n, εi was randomly sampled from N (0,1). Then for zi = 0,1
the potential outcomes for individual i were set to yi = 5 + 3zi + 2
∑
si + εi,
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where si = {z4b(i−1)/4c+1, . . . , z4di/4e}\zi. For example, s1 = {z2, z3, z4}, s2 =
{z1, z3, z4}, s3 = {z1, z2, z4}, s4 = {z1, z2, z3} and |si|= 3.
Step 2: Randomly generate covariate vector (L1i, . . . ,L4i) i.i.d from N(0, I4) for i =
1, . . .n, where I4 represents the 4 by 4 identity matrix. Let X1i = exp(L1i/2),
X2i = L2i/{1 + exp(L1i/2)}+ 10, X3i = (L1iL3i/25 + 0.6)3 and X4i = (L1i +
L4i + 20)2 be transformed covariates to be used in a misspecified propensity
score model.
Step 3: Let γ = (γ0,γ1,γ2,γ3,γ4) = (0.5,−1,0.5,−0.25,−0.1) and logit{f(Zi = z|b,L)}
= γ0 +γ1L1i +γ2L2i +γ3L3i +γ4L4i + bdi/4e where bv i.i.d. follows N(0,1) for
v= 1, . . . ,500 is the random effect and di/4e denotes the smallest integer greater
than or equal to i/4. Simulate Zi for i= 1, . . . ,n from the mixed effects logistic
distribution.
Step 4: Since the propensity scores are not known, we fit the correctly specified mixed
effects logistic regression model logit{f tru(Zi = z|b,L)}= γ0 +γ1L1i+γ2L2i+
γ3L3i+γ4L4i+bdi/4e and a misspecified mixed effects logistic regression model
logit{fmis(Zi = z|b,L)}= γ0+γ1X1i+γ2X2i+γ3X3i+γ4X4i+bdi/4e. Plugging
in the regression coefficient estimate γˆ and numerically integrating over the
estimated distribution of random effect b, we obtain fˆ(Zi = z|L) = ∫ f(Zi =
z|b,L, γˆ)φ(b, σˆ2b )db for the two models.
Step 5: Calculate the Ŷ ipw(z,α0), Ŷ haj1 (z,α0) and Ŷ
haj
2 (z,α0) for z = 0,1 using (i) the
known propensity score, (ii) the estimated propensity score from a correctly
specified mixed effects model and (iii) the estimated propensity score from a
misspecified mixed effects model.
Step 6: Repeat Step 3-5 1000 times and calculate the empirical bias, variance and mean
square error (MSE) of the estimators in Step 5.
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Table 3.1 shows the simulation results for a continuous outcome. All three esti-
mators are approximately unbiased when the propensity scores are known or when
the propensity score is correctly modeled but bias if incorrectly modeled. Also note
that Ŷ haj2 (·) has substantially smaller empirical square error (ESE) than Ŷ ipw(·) and
Ŷ haj1 (·). For example, when α = 0.1, the ESE of Ŷ ipw(1,α) is 1.48 when propensity
scores are known, 1.14 when the propensity score models are correctly specified and
1.79 if the covariates are not correctly specified. The ESE of Ŷ haj1 (1,α) is similar to
that of Ŷ ipw(·) while that of Ŷ haj2 (1,α) is around 0.03. This can be explained by the
larger variance of nˆ2,z compared with nˆ1,z, i.e., the denominator and numerator of the
Hajek 2 vary together. Also, in this simulation study, the Ŷ haj2 (·) is more robust than
Ŷ ipw(·) and Ŷ haj1 (·) when the propensity model is misspecified.
For binary outcome, the simulations were conducted similarly as for continuous
outcome but with the first step being replaced by the following:
Step 1: Of the 2000 individuals in the population, randomly assign 400 of the individ-
uals to have yi = 0, 400 of the individuals to have yi = 1, and the remaining
individuals to have yi = 1(zi = 1)1(si = |si|) for i= 1, . . . ,n.
The simulation results in this scenario are given in Table 3.2. Similar to the continuous
outcome simulations, the ESE for Ŷ haj2 (·) is smaller ESE than Ŷ ipw(·) and Ŷ haj1 (·)
under all three scenarios.
3.5 Rotavirus Vaccine Study in Nicaragua
Rotavirous is a major health problem in Nicaragua (Espinoza 1997). A rotavirus
vaccine study was carried out in Leo´n, Nicaragua’s second largest city with an estimated
2010 population of close to 200,000. The rotavirus vaccine was first introduced in Leo´n
in October 2006. Starting October 2006, any eligible child in the study at the age of 2, 4
and 6 months were offered rotavirus vaccine. However, for various reasons, the coverage
of vaccine of at least one dose was 67% after the implementation of the immunization
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program. In 2010, the Health and Demographic Surveillance Site-Leo´n (HDSS-Leo´n)
was employed to obtain a simple random sample of households from about 50 out of
208 randomly selected geographical clusters of equal size (Becker-Dreps et al 2013). For
the illustration purpose, we ignored the cluster sampling of households and the study
population is chosen to be 826 children from the households selected. There were 530
households in the study and any child in the selected household under the age of 5 was
eligible to participate. Each individual in the study was visited by a field worker every
two weeks for about a year (January 2010 to February 2011, except during Christmas
break). Information about the diarrhea episodes in past 14 days was recorded as well
as other information about the household such as the sanitation conditions, household
water source, maternal employment, and age of the child. Every child that participated
study is included in the analysis. There are around 300 children being the only kid
in the family. Including them will not be a problem for two reasons: First, they do
contribute to the direct effect. And second, in the IPW estimator they cancelled out
when calculating the indirect effect since the contrast function for all causal effects used
here is g(x1,x2) = x1−x2. The outcome is set to be whether a child had at least one
rotavirus diarrhea episode during the study.
We set the interference set to be children in the same household. A mixed effects
logistic regression model of the probability of choosing fully vaccination (individuals
are categorized as fully vaccinated, i.e., those who have all three doses and not fully
vaccinated, i.e., those who have less than three doses) at baseline was fitted conditional
on a subset of covariates available at baseline: child’s age (categorized into 0-11 months,
12-23 months and 24-59 months), mother’s education level, floor (dirt floor or not
dirt floor), season, household sanitation (indoor toilet, latrine or none), water (indoor
municipal water supply or not) and breastfeeding (yes or no). The likelihood ratio test
from the fitted logistic mixture model indicated that the probability of having all three
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doses of vaccine is higher among those whose mother is more educated (OR=1.96 with
p value= 0.01) or living in a house with better sanitation (OR=1.5 with p value=0.05),
the more likely a child would be vaccinated with all three doses. Table 3.3 shows the
estimates and the estimated SE of the IPW and two Hajek estimators. Results of
IPW and Hajek 1 are similar. The Hajek 2 estimates are closer to the null and as
expected have 15%-20% smaller SE than the IPW and Hajek 1 estimates. The direct
effect estimate curve and contour plots for indirect, total and overall effect estimators
are given in Figure 3.1. While the estimated direct effect declines as α increased, the
indirect, total and overall effect estimates became larger with increases in α1 for a
given level of α0. The rate of decline for the direct effect estimator is smaller as α
increases. Lines in the contour plot for the indirect effect estimates are not parallel and
are getting closer at the upper right corner, e.g., 10% of increase of vaccine coverage
at high coverage are estimated to have a stronger indirect effect compared to at low
coverage. This means that as the vaccine coverage for vaccinated children increased,
the risk of having rotavirus diarrhea among unvaccinated children decreased. The
contour plot lines are nearly vertical for the total effect estimates, indicating the vaccine
coverage does not have much effect on the risk of a vaccinated child having rotavirus
diarrhea. The Hajek 2 overall effect estimate provides a simple summary comparison
of the two strategies, indicating that, on average, 5.12 fewer cases per 100 individuals
in a household with coverage 0.8 compared with a household with coverage 0.1.
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3.6 Tables and Figures
Figure 3.1: Hajek 2 causal effect estimators for the rotavirus vaccine study
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Table 3.1: Comparison among Estimators, continuous outcome
Empirical Bias, empirical standard error (ESE) and the average estimated standard
error (ASE) of IPW and Hajek estimators for a continuous outcome with different α
when the propensity scores are known (Known f), unknown but correctly modeled
(Correct f), and unknown but incorrectly modeled (Mis f)
α
0.1 0.5 0.9
Known f Bias ESE ASE Bias ESE ASE Bias ESE ASE
Yˆ ipw(1,α) 0.035 1.48 1.46 0.004 0.68 0.68 0.029 1.57 1.57
Yˆ haj1 (1,α) 0.050 1.61 1.60 0.008 0.58 0.59 0.037 1.04 1.03
Yˆ haj2 (1,α) 0.009 0.03 0.03 0.001 0.02 0.02 0.005 0.01 0.01
Correct f Bias ESE ASE Bias ESE ASE Bias ESE ASE
Yˆ ipw(1,α) 0.036 1.14 1.06 0.151 0.34 0.30 0.442 0.67 0.60
Yˆ haj1 (1,α) 0.039 1.14 1.12 0.154 0.33 0.37 0.436 0.62 0.69
Yˆ haj2 (1,α) 0.008 0.03 0.03 0.023 0.01 0.01 0.032 0.01 0.01
Mis f Bias ESE ASE Bias ESE ASE Bias ESE ASE
Yˆ ipw(1,α) 0.566 1.79 1.25 0.154 2.53 1.45 1.574 13.74 9.28
Yˆ haj1 (1,α) 0.721 1.43 1.23 0.387 1.21 0.95 1.224 5.68 5.08
Yˆ haj2 (1,α) 0.007 0.03 0.02 0.112 0.03 0.02 0.071 0.01 0.01
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Table 3.2: Comparison among estimators, binary outcome
Empirical Bias (×10), empirical standard error (ESE) (×10) and the average
estimated standard error (ASE) (×10) of IPW and Hajek estimators for a binary
outcome with different α when the propensity scores are known (Known f), unknown
but correctly modeled (Correct f), and unknown but incorrectly modeled (Mis f)
α
0.1 0.5 0.9
Known f Bias ESE ASE Bias ESE ASE Bias ESE ASE
Yˆ ipw(1,α) 0.013 0.68 0.68 0.004 0.27 0.27 0.022 0.71 0.71
Yˆ haj1 (1,α) 0.010 0.68 0.68 0.004 0.25 0.25 0.027 0.61 0.61
Yˆ haj2 (1,α) 0.021 0.56 0.54 0.001 0.23 0.22 0.019 0.24 0.24
Correct f Bias ESE ASE Bias ESE ASE Bias ESE ASE
Yˆ ipw(1,α) 0.019 0.72 0.69 0.005 0.23 0.24 0.279 0.49 0.46
Yˆ haj1 (1,α) 0.020 0.72 0.70 0.004 0.23 0.24 0.275 0.47 0.48
Yˆ haj2 (1,α) 0.018 0.58 0.54 0.052 0.22 0.20 0.078 0.20 0.20
Mis f Bias ESE ASE Bias ESE ASE Bias ESE ASE
Yˆ ipw(1,α) 0.145 0.60 0.55 0.079 0.58 0.48 0.914 1.99 1.65
Yˆ haj1 (1,α) 0.181 0.56 0.53 0.015 0.41 0.39 0.743 1.35 1.27
Yˆ haj2 (1,α) 0.013 0.49 0.45 0.149 0.28 0.25 0.167 0.30 0.30
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Table 3.3: Rotavirus Vaccine Study
IPW and Hajek estimates (Est) and estimated standard error (SE) per 100
individuals for the rotavirus vaccine study
α
0.2 0.4 0.6 0.8
Est SE Est SE Est SE Est SE
D̂E
ipw(α) -7.94 20.3 -6.15 15.2 -4.20 10.4 -1.85 6.82
D̂E
haj
1 (α) -8.11 20.4 -6.30 15.3 -4.33 10.6 -1.96 7.05
D̂E
haj
2 (α) -5.16 17.3 -4.37 13.0 -3.21 9.21 -1.41 6.45
ÎE
ipw(α,0.1) -1.32 2.59 -4.04 7.78 -6.88 13.0 -9.82 18.4
ÎE
haj
1 (α,0.1) -1.32 2.58 -4.06 7.77 -6.92 13.0 -9.88 18.4
ÎE
haj
2 (α,0.1) -0.42 2.43 -1.53 6.96 -2.85 11.4 -4.49 15.8
T̂E
ipw(α,0.1) -9.26 22.8 -10.2 22.6 -11.1 22.6 -11.7 22.7
T̂E
haj
1 (α,0.1) -9.43 22.9 -10.4 22.7 -11.3 22.7 -11.9 22.7
T̂E
haj
2 (α,0.1) -5.58 19.5 -5.90 19.4 -6.06 19.4 -5.90 19.5
ÔE
ipw(α,0.1) -2.00 4.30 -5.60 11.4 -8.49 16.4 -10.4 19.5
ÔE
haj
1 (α,0.1) -2.03 4.31 -5.67 11.4 -8.60 16.5 -10.5 19.5
ÔE
haj
2 (α,0.1) -0.88 3.76 -2.70 9.82 -4.24 14.1 -5.12 16.8
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Chapter 4
Doubly Robust Estimation with Interference
4.1 Introduction
In causal inference, it is typically assumed that individual’s potential outcome de-
pends only on the her own treatment assignment. This is part of the stable unit
treatment value assumption (Rubin 1980). However, this assumption does not hold in
various settings. For example, in a vaccine trial, the infection status of one individual
depends on her vaccination status as well as the vaccination of people she commonly
contact with. In econometrics, the house mobility may depends on the distribution of
voucher in the neighbourhood (Sobel 2006). Recently, the situation has been studied
where the study population can be divided into clusters and possible interference exists
only among individuals in the same cluster. This is called ‘partial interference’ (Sobel
2006) and can be viewed as a special case of ‘constant treatment response’ (Manski
2013). Assuming partial interference, Hudgens and Halloran (2008) defined the direct,
indirect (or spillover), total, and overall causal effects of an intervention and Tchet-
gen Tchetgen and VanderWeele (2012) proposed inverse probability weighted (IPW)
estimators of these causal effect for observational studies. However, the validity of
IPW estimators only holds when the propensity score is known or correctly modeled.
Moreover, IPW estimators are known to have large variance and are unstable to small
propensity scores which are quite common in a study with interference. Thus, new
methods need to be developed to improve the efficiency and stabilize IPW estimators.
In the absence of interference, doubly robust (DR) procedure are known to be ef-
fective in improving on the IPW estimators. Usually, when the missing mechanism of
outcomes are beyond the control of the investigators, there are two ways of adjusting for
potential confounders. One is to model the relationship between covariates and poten-
tial outcomes and the other is to predict the missing mechanism using the information
available. IPW estimators only use the second model while DR estimators apply both
model and is proved to be consistent when either of the two models is correct (Robins
and Rotnitzky 1995). In practice, neither the model for the propensity score nor the
counterfactual outcome model is known to investigators. Thus, the DR estimator pro-
vides 2 chances to get a right answer. However, the literature of DR procedure all make
the no interference between units assumption and hence there is a need to generalize
the DR estimator in the presence of interference.
In this paper, we develop the DR estimators for causal effects in studies assuming
partial interference. The outline of the remainder of the paper is as follows. In Section
4.2 we introduce notation and define various causal effects. The IPW and regression
estimators are defined in Section 4.3.1 and the DR estimator is derived in Section 4.3.2.
Results from a simulation study are presented in Section 4.4. The rotavirus vaccine
study is introduced in Section 4.5. Method will be illustrated in an application to this
study. Finally, we discuss some limitations and propose future research in Section 4.6.
4.2 Notations, Assumptions and Estimands
Let Y be the continuous or discrete outcome and let X denote the pre-exposure
covariates. Let A be the random variable for the treatment received and let A = 1 if
individual receives treatment and A= 0 otherwise. Suppose there are m groups in the
study with ni individuals in group i. For each individual, a copy of (Xij ,Aij ,Yij) will be
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observed for j = 1, . . . ,ni, i = 1, . . . ,m. Let Xi = (Xi1, . . . ,Xini) and Yi = (Yi1, . . . ,Yini)
be the random vector of the covariates and outcome for all individuals in group i. Let
Ai = (Ai1, . . . ,Aini) denote the random vector of treatment received for all ni individu-
als in group i and Ai(−j) = Ai\Aij be the subvector of Ai denoting the random vector
of treatment for all individuals other than the jth one. Let aij , ai(−j) and ai denote
the possible value Aij , Ai(−j) and Ai can take. Define f(Ai|Xi) = Pr(Ai|Xi) to be the
probability of treatment vector given the covariates (also known as propensity score)
and let f(Aij |Xi) = Pr(Aij |Xi) be the probability of treatment received by an individ-
ual. A special interference structure is that individuals interfere with each other within
the same group but not across groups. This is called partial interference assumption
and we make this assumption throughout. Under partial interference assumption, let
Y (ai) = Y (aij ,ai(−j)) be the potential outcome under treatment allocation ai, and thus
Y =∑ai 1(Ai = ai)Y (ai). In a study with partial interference, the copies (Xij ,Aij ,Yij)
may be dependent but identically distributed and (Xi,Ai,Yi) are indeed independent.
We assume that conditional on covariates Li, the treatment allocation is positive, i.e.,
f(Ai = Ai|Xi) > 0 with probability 1. We also make the exchangeability assumption
that f(Ai|Li) = f(Ai|Xi,Yi(·)). This is also known as the ignorability assumption in
missing data literature. We make these two assumptions throughout.
We say the treatment assignment is ‘allocation strategy αk’ if individuals are inde-
pendently assigned treatment with probability αk. Under allocation strategy αk, the
probability of having treatment Ai in group i is pi(Ai;αk) = Pr(Ai;αk) =
∏
j α
Aij
k (1−
αk)1−Aij and that of the individuals other than individual j is pi(Ai(−j);αk) = Pr(Ai(−j);αk)
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= ∏j′ 6=j αAij′k (1−αk)1−Aij′ . Define the average potential outcome under allocation s-
trategy αk as y(a,αk) =
∑
ai(−j)EY (a,ai(−j))pi(ai(−j);αk) is the average potential out-
come conditional on covariates Xi when individual is assigned treatment a under alloca-
tion strategy αk. Define the average potential outcome conditional on covariates Xi un-
der allocation αk to be y(α0) =
∑
aiEY (ai)pi(ai;α0). Following Halloran and Struchiner
(1995) and Hudgens and Halloran (2006) , we define the direct effect of a treatment
under allocation strategy αk to be DE(αk) = y(1,αk)−y(0,αk) for k= 0,1, the indirect
effect IE(α1,α0) = y(0,α1)− y(0,α0), the total effect TE(α1,α0) = y(1,α1)− y(0,α0),
and the overall effect OE(α1,α0) = y(α1)− y(α0). In words, the direct effect is the
effect of applying treatment directly. Indirect (or spillover) effect compares the average
potential outcome when an individual receives control under different allocation strat-
egy α1 and α0. The total effect equals the sum of the direct and indirect effects, while
the overall effect provides a single summary measure of the effect of allocation strategy
α1 versus α0. See Tchetgen Tchetgen and VanderWeele (2012) for further discussion
about these estimands.
4.3 Estimators
4.3.1 IPW and Regression Estimators
One way to adjust for the confounding in observational studies is to use inverse-
weighting. Inverse probability weighting creates a pseudo-population, in which there
is no confounding thus the weighted average represent the average in a population
where the treatment is randomly assigned. Under no unmeasured confounders assump-
tion, Y (ai) is independent with Ai given f(Ai|Xi). However, the propensity score
is usually not known but estimated. For example, after fitting the regression mod-
el f(Ai|Xi) = exp(γ1 + γXiXi + γAiAi)/{1 + exp(γ1 + γXiXi + γAiAi)}, the maximum
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likelihood estimates (MLE) γˆ = (γˆ1, γˆXi , γˆAi) for γ = (γ1,γXi ,γAi) can be calculated
and thus fˆ(Ai|Xi) can be obtained. Tchetgen Tchetgen and VanderWeele (2012)
proposed group level generalized IPW estimator as Ŷ ipwi (a;αk) = n−1i
∑ni
j=1 1(Aij =
a)Yij(Ai)pi(Ai(−j);αk)/fˆ(Ai|Xi) and Ŷ ipwi (αk) = n−1i
∑ni
j=1Yij(Ai)pi(Ai;α0)/fˆ(Ai|Xi).
The population level IPW estimators were Ŷ ipw(a;αk) =
∑m
i=1 Ŷ
ipw
i (a;αk)/m and Ŷ ipw(αk) =∑m
i=1 Ŷ
ipw
i (αk)/m. It has been showed that when the propensity score is known, the
generalized IPW estimators Ŷ ipwi (a,αk) and Ŷ
ipw
i (αk) are unbiased for y(a,αk) and
y(αk), k = 0,1. We assume under certain regularity conditions, there exists γ∗ such
that γˆ→ γ∗ as m→∞, that is the estimator γˆ will converge no matter the propensity
model is correct or not. Thus, if the if the propensity score f(Ai|Xi) is unknown but cor-
rectly modeled, i.e., γ∗ = γ0 where γ0 is the true parameter then Ŷ ipw(a,αk)
p−→ y(a,αk)
and Ŷ ipw(αk)
p−→ y(αk) as m→∞.
Alternatively, one can adjust for potential confounders using a regression estimator
based on the imputed value of potential outcomes. For example, suppose the true re-
gression model for Y (Ai) is µ(Ai,Xi) = E[Y (Ai)|Ai,Xi] = β0 +βAiAi +βXiXi. Then,
the group level regression estimators are defined as Ŷ regi (a;αk) =
ni∑
j=1
∑
ai(−j)
µˆij(a,ai(−j),Xi)
pi(ai(−j);αk)/ni and Ŷ
reg
i (αk) =
∑ni
j=1
∑
ai µˆi(ai,Xi)pi(ai;αk)/ni where µˆij(aij ,ai(−j),Xi)
= µˆij(ai,Xi) = βˆ1+ βˆAiai+ βˆXiXi and βˆ = (βˆ1, βˆAi , βˆXi) are MLE for β = (β1,βAi ,βXi).
The population level regression estimators are defined as Ŷ reg(a;αk) =
m∑
i=1
Ŷ regi (a;αk)/m
and Ŷ reg(αk) =
∑m
i=1 Ŷ
reg
i (αk)/m. We assume under certain regularity conditions, there
exist β∗ such that βˆ → β∗ as m→∞. Note that if the potential outcome model
m(ai,Xi) is consistently estimated by mˆ(ai,Xi), i.e., β∗ = β0 where β0 is the true
parameter, then Ŷ reg(a,αk)
p−→ y(a,αk) and Ŷ reg(αk) p−→ y(αk) as m→∞.
We can define various causal effect estimators based on the IPW and regression
estimators introduced in this section. For example, define D̂Eipw(αk) = Ŷ ipw(1,αk)−
Ŷ ipw(0,αk) for k = 0,1 to be the IPW estimator for direct effect, ÎE
ipw(α1,α0) =
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Ŷ ipw(0,α1)−Ŷ ipw(0,α0), T̂Eipw(α1,α0) = Ŷ ipw(1,α1)−Ŷ ipw(0,α0) and ÔEipw(α1,α0) =
Ŷ ipw(α1)− Ŷ ipw(α0) to be the IPW estimators for indirect, total and overall effects.
The regression causal effect estimators can be defined similarly. Note that these estima-
tors are consistent estimator for corresponding causal effects when the model required
is correctly specified.
4.3.2 Doubly Robust Estimators
In Section 4.3.1, we have shown that in an observational study with interference, the
parameter of interest y(a,αk) and y(αk) can be consistently estimated by the estimator
based on regression modeling if the regression model is correct or by the estimator based
on inverse propensity weighting if the propensity score model is correct. The doubly
robust estimators utilize both models and are consistent if either model is correct. We
propose doubly robust estimators as follows:
Ŷ DRi (a,αk) = n−1i
ni∑
j=1
1(Aij = a){Yij(Ai)− µˆij(Ai,Xi)}fˆ(Ai|Xi) pi(Ai(−j);αk)
+
∑
ai(−j)
µˆij(a,ai(−j),Xi)pi(ai(−j);αk)

Ŷ DRi (αk) = n−1i
n∑
j=1
{{Yij(Ai)− µˆij(Ai,Xi)}
fˆ(Ai|Xi)
pi(Ai;αk) +
∑
ai
µˆij(ai,Xi)pi(ai;αk)
}
where fˆ(Ai|Xi) and µˆij(ai,Xi) are parametric model built for propensity score and the
outcome. Under certain regularity conditions For the group level and Ŷ DR(a,αk) =∑m
i=1 Ŷ
DR
i (a,αk)/m and Ŷ DR(αk) =
∑m
i=1 Ŷ
DR
i (αk)/m at the population level. The
following Proposition shows that the DR estimators are indeed doubly robust.
Proposition 1. If either γ∗ = γ0 or β∗ = β0 hold, then
(a)
√
m{Ŷ DR(a,αk)−y(a,αk)}/σDR(a,αk) d−→N(0,1) as m→∞, where (σDR(a,αk))2
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=m−1∑mi=1ψ2i (y(a,αk),γ∗,β∗) and ψi(η,γ,β) =∑nij=1[1(Aij = a){Y (Ai)−µ(Ai,Xi|β)}
pi(Ai(−j);α0)/{nif(Ai|Xi,γ)}+
∑
ai(−j) µ(a,ai(−j),Xi|β)pi(ai(−j);α0)]−η
(b)
√
m{Ŷ DR(αk)− y(αk)}/σDR(αk) d−→ N(0,1) as m→∞, where (σDR(αk))2 =
m−1
∑m
i=1ϕ
2
i (y(αk),γ∗,β∗) and ϕi(η,γ,β) =n−1i
ni∑
j=1
[{Y (Ai)−µ(Ai,Xi|β)}pi(Ai(−j);α0)/
f(Ai|Xi,γ) +∑ai µ(ai,Xi|β)pi(ai;α0)]−η.
The proof of Proposition 1 is given in the Appendix. It can also be concluded from
the proof that σDR(a,αk) and σDR(αk) stay the same whether γ and β are known
or estimated. To estimate the variance, note that ψi(Ŷ DR(a,αk), γˆ, βˆ) = Ŷ DRi (a,αk)−
Ŷ DR(a,αk), thus, (σˆDR(a,αk))2 =m−1
∑m
i=1(Ŷ DRi (a,αk)− Ŷ DR(a,αk))2 is a consistent
estimator for (σDR(a,αk))2. Similarly, (σˆDR(αk))2 =m−1
∑m
i=1(Ŷ DRi (αk)− Ŷ DR(αk))2
estimates (σDR(αk))2 consistently.
Doubly robust causal effect estimators can be defined similarly as the IPW estima-
tors in Section 4.3.1. For example, define D̂EDR(αk) = Ŷ DR(1,αk)− Ŷ DR(0,αk) to be
the DR estimator for direct effect. And it follows from Proposition 1 that D̂EDR(αk),
ÎE
DR(α1,α0), T̂E
DR(α1,α0) and ÔE
DR(α1,α0) are consistent estimators for the cor-
responding causal effects when either the propensity or the potential outcome model is
correct. Thus, these estimators are doubly robust as well.
Proposition 2. If either γ∗ = γ0 or β∗ = β0 hold, then
(a)
√
m{D̂EDR(αk)−DE(αk)}/σDRD d−→N(0,1) as m→∞, where (σDRD )2 =m−1
∑m
i=1
{ψi(y(1,αk),γ∗,β∗)−ψi(y(0,αk),γ∗,β∗)}2
(b)
√
m{ÎEDR(α1,α0)− IE(α1,α0)}/σDRI d−→ N(0,1) as m→∞, where (σDRI )2 =
m−1
∑m
i=1{ψi(y(0,α1),γ∗,β∗)−ψi(y(0,α0),γ∗,β∗)}2
(c)
√
m{T̂EDR(α1,α0)−TE(α1,α0)}/σDRT d−→N(0,1) as m→∞, where (σDRT )2 =
m−1
∑m
i=1{ψi(y(1,α1),γ∗,β∗)−ψi(y(0,α0),γ∗,β∗)}2
(d)
√
m{ÔEDR(α1,α0)−OE(α1,α0))}/σDRO d−→N(0,1) as m→∞, where (σDRO )2 =
m−1
∑m
i=1{ϕi(y(α1),γ∗,β∗)−ϕi(y(α0),γ∗,β∗)}2
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Following a similar argument as previously, a consistent estimator for (σDRD )2 is
(σˆDRD )2 = (D̂E
DR
i (αk)−D̂E
DR(αk))2. Consistent variance estimator for the other three
causal effects can be construct similarly.
4.4 Simulations
Simulations were conducted to verify the unbiasedness and consistency of the IPW,
regression and DR robust estimators given in Sections 4.3.1 and 4.3.2 as well as to
compare their efficiency and robustness when the model is either correctly or mistakenly
specified. Simulations were conducted under four scenarios: (i) the propensity model is
correct but the potential outcome model is wrong, (ii) the propensity model is wrong but
the potential outcome model is correct, (iii) both the propensity model and the potential
outcome model are correct, and (iv) neither the propensity model or the potential
outcome model is correct. For scenario (i), the simulation study was conducted in the
following steps:
Step 1: Covariates (Z1ij ,Z2ij ,Z3ij ,Z4ij) were independently sampled from N(0,I4) for
j = 1, . . . ,ni, i = 1, . . . ,m, where I4 are 4 by 4 identity matrix. Let X1ij =
exp(Z1ij/2), X2ij = Z2ij/{1 + exp(Z1ij)}+ 10, X3ij = (Z1ijZ3ij/25 + 0.6)3 and
X4ij = (Z1ij +Z4ij + 20)2.
Step 2: Let logitPr(Aij = 1|Z1i, . . . ,Z4i, bi) = −Z1ij + 2Z2ij − 1.25Z3ij − 0.1Z4ij + bi
where bi i.i.d. follows N(0,1) for i = 1, . . . ,500 is the random effect. Simu-
late Aij from the mixed effect logistic distribution.
Step 3: Let µij = 2−Z1ij − 2.7Z2ij + 3Z3ij −Z4ij + 0.5Aij + 6f(Ai(−j))/ni+AijZ1ij +
8f(Ai(−j))Z2ij where f(Ai(−j)) =
∑ni
j
′=1,j′ 6=jAij′/ni is proportion of treatment
received among people in the rest of group i. Randomly sample εi from N(0,1)
and let Yij = µij + εij .
Step 4: Fit the correct potential outcome model E{Yij |Z1i, . . . ,Z4i,Ai}= β1+β1Z1ij +
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β2Z2ij+β3Z3ij+β4Z4ij+β5Aij+β6f(Ai(−j))+β7AijZ1ij+β8f(Ai(−j))Z2ij and
the mis-specified propensity model logitPr(Aij = 1|X1i, . . . ,X4i, bi) = γ1X1ij +
γ2X2ij + γ3X3ij + γ4X4ij + bi. Calculate the MLE βˆ and γˆ and thus obtain
the estimated outcome mˆij(ai,Xi) and propensity score fˆ(Aij = 1|Xi) for
j = 1, . . . ,ni, i= 1, . . . ,m.
Step 5: Calculate the IPW, regression and DR estimators according to Section 4.3.1
and 4.3.2.
Step 6: Repeat Step 1-5 for 500 times and calculate the empirical mean and variance
of these estimators.
The simulation was carried out for ni = 4, m= 500 and α0 took the value 0.1, 0.5 and
0.9. Scenario (ii) was carried out similar as Scenario (i) except replace Step 4 with
Step 4: Fix the mis-specified potential outcome model E{Yij |X1i, . . . ,X4i,Ai} = β1 +
β1X1ij+β2X2ij+β3X3ij+β4X4ij+β5Aij+β6f(Ai(−j))+β7AijX1ij+β8f(Ai(−j))X2ij
and the correct propensity model logitPr(Aij = 1|Z1i, . . . ,Z4i, bi) = γ1Z1ij +
γ2Z2ij+γ3Z3ij+γ4Z4ij+bi. Calculate the MLE βˆ and γˆ and thus obtain the es-
timated outcome mˆi(ai,Xi) and propensity score fˆ(Aij = 1|Xi) for j = 1, . . . ,ni,
i= 1, . . . ,m.
And Scenario (iii) and (iv) were carried out using the corresponding regression model.
The simulation result is presented in Table 4.1. As expected, when the pi model
is correct, the IPW, hajek and the DR estimators have small bias while when the µ
model is correct, the regression and DR estimators have small bias. Note that the DR
estimator has a smaller variance than that of the IPW estimators when the pi model
is correct; the DR estimator has a smaller variance than that of both the regression
estimators when the µ model is correct. That is when one of the model is correct,
the other model in DR estimator, although mis-specified, helps increase the efficiency.
When both models are correct, the DR estimator has even smaller bias and variance.
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However, when both models are wrong, the DR estimator has as big or even bigger bias
when using the IPW and regression estimators. This is also observed by who pointed
out that ‘two wrong models are not better than one’.
4.5 Rotavirus Vaccine Study in Nicaragua
Rotavirous is a major health problem in Nicaragua (Espinoza 1997). A rotavirus
vaccine study was carried out in Leo´n, Nicaragua’s second largest city, with an esti-
mated 2010 population of close to 200,000. The rotavirus vaccine was first introduced
in Leo´n in October 2006. In 2010, the Health and Demographic Surveillance Site-Leo´n
(HDSS-Leo´n) was employed to obtain a simple random sample of households from about
50 out of 208 randomly selected geographical clusters of equal size (Becker-Dreps et al
2013). There were 530 households in the study and any child in the selected household
under the age of 5 was eligible to participate. Starting October 2006, any eligible child
in the study at the age of 2, 4 and 6 months were offered rotavirus vaccine. However,
due to various reasons, the coverage of vaccine of at least one dose was about 67%
after the implementation of immunization program. Each individual in the study was
visited by a field worker every two weeks for about a year (January 2010 to February
2011, except during Christmas break). During each visit, information about the diar-
rhea episodes in the past 14 days was recorded as well as other information about the
household such as the sanitation conditions, water source, or the mother or the child
such as maternal employment or age of the child. Every child participated study is
included in the analysis. There are around 300 children out 826 children being the only
kid in the family. Including them will not be a problem for two reasons: First, they
do contribute to the direct effect. And second, in the IPW estimator they cancelled
out when calculating the indirect effect since the contrast function for all causal effects
used here is g(x1,x2) = x1−x2. The outcome is set to be whether one child ever had
rotavirus diarrhea episode during the study.
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A logistic regression model of the probability of choosing vaccine (all three doses)
at baseline was fitted on the covariates available at baseline: child’s age (categorized
into 0-11 months, 12-23 months and 24-59 months), mother’s education level, floor
(dirt floor or not dirt floor), season, household sanitation (indoor toilet, latrine or
none), water (indoor municipal water supply or not) and breastfeeding (yes or no).
The likelihood ratio test from the fitted logistic mixture model indicated that the
probability of having all three doses of vaccine is higher among those whose mother
has a higher education level categorized age variable has p value 0.001. Also, the more
educated the mother (OR=1.96 with p value= 0.01) or those in a house with better
sanitation (OR=1.5 with p value=0.05). Then we fit a linear regression model for
outcomes. Apart from all the covariates included in the propensity score model, we
include individual vaccine status (all 3 doses) and the proportion of vaccine received
in the household. Compared with 24-59 month old children, infants are more likely
to have rotavirus diarrhea (OR=1.09 with p value 0.02). Also, rotavirus diarrhea is
more likely to happen in the dry season (OR=1.11 with p value¡0.001). Mothers with
a higher education level or those breastfeeding their children are more likely to report
diarrhea. Table 4.2 shows the estimates of IPW, regression and DR estimators.
4.6 Discussion
So far, we have proposed to extend the doubly robust estimators in the presence of
interference. The DR estimators of various causal effects were proposed and showed to
be consistent and asymptotical normally distributed. The DR estimators we proposed
use only one model for propensity score and one for potential outcome. However, it was
suggested in the absence of interference that estimators using multiple models for both
the propensity score and potential outcome are more robust than DR (Han and Wang
2013). Also, Tsiatis (2006) proposed DR estimator that achieved the semiparametric
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efficiency bound. How these results can be generated in the presence of interference is
left for future work.
4.7 Tables and Figures
Table 4.1: Bias and SE of Estimators
Empirical bias and standard error (in parentheses) of different estimators when
interference is at present, ni = 4 and m= 500
α
0.1 0.5 0.9
pi tru µ mis Bias ESE ASE Bias ESE ASE Bias ESE ASE
Yˆ ipw(1,α0) 0.032 0.77 0.80 0.066 0.29 0.31 0.198 0.38 0.42
Yˆ reg(1,α0) 0.284 0.71 0.17 0.220 0.40 0.11 0.157 0.27 0.14
Yˆ DR(1,α0) 0.013 0.55 0.55 0.004 0.19 0.19 0.007 0.19 0.18
pi mis µ tru Bias ESE ASE Bias ESE ASE Bias ESE ASE
Yˆ ipw(1,α0) 0.706 0.70 0.83 0.139 3.05 4.37 0.756 2.29 3.10
Yˆ reg(1,α0) 0.004 0.14 0.10 0.002 0.09 0.08 0.001 0.11 0.10
Yˆ DR(1,α0) 0.005 0.20 0.20 0.010 0.23 0.23 0.000 0.19 0.19
pi tru µ tru Bias ESE ASE Bias ESE ASE Bias ESE ASE
Yˆ DR(1,α0) 0.006 0.17 0.17 0.001 0.09 0.09 0.003 0.11 0.11
pi mis µ mis Bias ESE ASE Bias ESE ASE Bias ESE ASE
Yˆ DR(1,α0) 0.501 0.76 0.79 0.246 2.07 2.08 0.094 1.29 1.28
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Table 4.2: Estimators for Rotavirus Vaccine Study
IPW, regression and DR estimates (Est) and estimated standard error (SE) per 100
individuals for the rotavirus vaccine study
α1
0.2 0.4 0.6 0.8
Est SE Est SE Est SE Est SE
D̂E
ipw(α1) -6.30 10.30 -3.90 7.90 -1.60 5.80 0.80 4.30
D̂E
reg(α1) 5.30 4.70 5.30 4.70 5.30 4.70 5.30 4.70
D̂E
DR(α1) -6.10 10.10 -4.20 7.90 -2.10 5.90 0.40 4.40
ÎE
ipw(α1,0.1) -1.20 1.30 -3.50 3.90 -5.80 6.50 -8.20 9.10
ÎE
reg(α1,0.1) 2.20 2.30 6.70 6.90 11.10 11.50 15.60 16.10
ÎE
DR(α1,0.1) 1.30 1.20 3.70 3.70 6.10 6.10 8.50 8.50
T̂E
ipw(α1,0.1) -7.40 11.50 -7.40 11.50 -7.50 11.50 -7.40 11.50
T̂E
reg(α1,0.1) 7.50 5.50 12.00 8.80 16.40 12.90 20.90 17.30
T̂E
DR(α1,0.1) -4.90 11.30 -0.50 11.30 4.10 11.30 8.90 11.30
ÔE
ipw(α1,0.1) -1.70 2.10 -4.30 5.70 -6.10 8.20 -6.90 9.80
ÔE
reg(α1,0.1) 2.80 2.40 8.30 7.20 13.80 12.00 19.30 16.80
ÔE
DR(α1,0.1) 0.70 2.10 2.80 5.50 5.60 8.00 9.50 9.60
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Chapter 5
Conclusion
To summarize, assessing the causal effect in the presence of interference can be dif-
ficult in many settings. We have provided methodology to make causal inference about
treatment effects when the population consists of groups of individuals where interfer-
ence is possible within groups but not between groups. The asymptotic distributions of
effect estimators were derived when either the number of individuals per group or the
number of groups grows large. Under certain assumptions about homogeneity across
groups, the asymptotic distributions provide justification for Wald type CIs and tests.
A simulation study was presented showing that in some settings the Wald CIs have
good coverage in finite samples and are substantially narrower than exact CIs.
Additionally, we generalized the IPW estimator proposed by Tchetgen Tchetgen and
VanderWeele (2012) for general interference structure in observational studies. Specif-
ically, first we propose generalized IPW estimators that do not require the partial
interference; rather any form of interference between individuals is permitted. Second,
two stabilized IPW estimators are proposed based on the classic Hajek estimator from
survey sampling. Third, we develop the asymptotic distribution of IPW estimators and
Hajek estimators and propose consistent variance estimators assuming partial interfer-
ence. Empirical results are presented demonstrating one of the Hajek estimators can
have substantially smaller variance than the other IPW estimators.
Chapter 4 provides a way to construct doubly robust estimators for causal effects in
the presence of interference. These estimators are generalization of doubly robust esti-
mator for average treatment effect. The doubly robust estimators proposed are shown
to be consistent and asymptotically normally distributed when either the propensity
score or the potential outcome is correctly modeled. Both the Hajek estimators and
the DR estimators are illustrated using data from a recent study examining the effects
of rotavirus vaccination in Nicaragua.
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Appendix I
Proofs from Chapter 2
Proof of Propositions 1-3
Proposition 1 follows directly from Lehmann (1998) Appendix 4 Theorem 6. To
prove Proposition 2, set Sni(α1) =
∑ni
j=1υij1(Zij = 1) and note the same theorem from
Lehmann (1998) implies
[Sni(α1)−Eα1{Sni(α1)}]/
√
V arα1{Sni(α1)} d−→N (0,1) (5.1)
where Eα1{Sni(α1)}= E{Sni(α1)|Gi = 1}. Next note that
D̂Ei(α1) = Ŷi(1,α1)− Ŷi(0,α1)
= 1
kiα1
ni∑
j=1
yij(1,α1)1(Zij = 1)− 1
ni−kiα1
ni∑
j=1
yij(0,α1)1(Zij = 0)
= 1
kiα1
ni∑
j=1
yij(1,α1)1(Zij = 1)− 1
ni−kiα1
ni∑
j=1
yij(0,α1){1−1(Zij = 1)}
=
ni∑
j=1
{
1
kiα1
yij(1,α1) +
1
ni−kiα1
yij(0,α1)
}
1(Zij = 1)− 1
ni−kiα1
ni∑
j=1
yij(0,α1)
implying
D̂Ei(α1)−DEi(α1) =
ni∑
j=1
{
1
kiα1
yij(1,α1) +
1
ni−kiα1
yij(0,α1)
}
1(Zij = 1)
− 1
ni−kiα1
ni∑
j=1
yij(0,α1)− 1
ni
ni∑
j=1
yij(1,α1) +
1
ni
ni∑
j=1
yij(0,α1)
=
ni∑
j=1
{
1
kiα1
yij(1,α1) +
1
ni−kiα1
yij(0,α1)
}
1(Zij = 1)
−
ni∑
j=1
{
1
kiα1
yij(1,α1) +
1
ni−kiα1
yij(0,α1)
}
kiα1
ni
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such that D̂Ei(α1)−DEi(α1) =Sni(α1)−Eα1{Sni(α1)}. Also note D̂Ei(α1) =Sni(α1)−∑ni
j=1 yij(0,α1)/(ni− kiα1), i.e., D̂Ei(α1) and Sni(α1) differ by a constant. Therefore
V arα1{D̂Ei(α1)}= V arα1{Sni(α1)}, implying
D̂Ei(α1)−DEi(α1)√
V arα1{D̂Ei(α1)}
= Sni(α1)−Eα1{Sni(α1)}√
V arα1{Sni(α1)}
which by (5.1) completes the proof of Proposition 2. Using the fact that Ŷi(αs)−
Y i(αs) =
∑ni
j=1
{
yij(1,αs)− yij(0,αs)
}{
1(Zij = 1)− kiαs/ni
}
/ni, Proposition 3 can be
proved similarly to Proposition 2.
Proof of Propositions 4.1-4.4
To prove Proposition 4.1, let {i1, . . . , il}= {i ∈ {1, . . . ,m} :Gi = 1} and let
ci = lim
√
V arα1{D̂Ei(α1)}/
√∑
i∈{i1,...,il}V arα1{D̂Ei(α1)} as nmin→∞ for i∈{i1, . . . , il}.
By assumption ci1 , . . . , cil exist. Then conditional on G1 = g1, ...,Gm = gm,
D̂E(α1)−µ(i1,...,il)DE
σ
(i1,...,il)
DE
=
∑
i∈{i1,...,il}
[D̂Ei(α1)−Eα1{D̂Ei(α1)}]√ ∑
i∈{i1,...,il}
V arα1{D̂Ei(α1)}
=
∑
i∈{i1,...,il}
[D̂Ei(α1)−Eα1{D̂Ei(α1)}]√
V arα1{D̂Ei(α1)}
√
V arα1{D̂Ei(α1)}√ ∑
i∈{i1,...,il}
V arα1{D̂Ei(α1)}
d−→ ∑
i∈{i1,...,il}
Zici ∼N (0,1)
where Zi1 , . . . ,Zil are i.i.d N (0,1) and the last line follows from Proposition 2 and that∑
i∈{i1,...,il} c
2
i = 1.
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To prove Proposition 4.2, note that
ÎE(α1,α0) = Ŷ (0,α1)− Ŷ (0,α0)
=
m∑
i=1
{
Ŷi(0,α1)
l
1(Gi = 1)− Ŷi(0,α0)
m− l 1(Gi = 0)
}
Thus conditional on
{
Gi = 1 : i ∈ {i1, . . . , il}
}
,
ÎE(α1,α0)−µ{i1,...,il}IE
σ
{i1,...,il}
IE
=
∑
i∈{i1,...,il}
Ŷi(0,α1)−yi(0,α1)
lσ
{i1,...,il}
IE
− ∑
i/∈{i1,...,il}
Ŷi(0,α0)−yi(0,α0)
(m− l)σ{i1,...,il}IE
=
∑
i∈{i1,...,il}
Ŷi(0,α1)−yi(0,α1)√
V arα1Ŷi(0,α1)
√
V arα1Ŷi(0,α1)/l2
σ
{i1,...,il}
IE
− ∑
i/∈{i1,...,il}
Ŷi(0,α0)−yi(0,α0)√
V arα1Ŷi(0,α1)
√
V arα1Ŷi(0,α1)/(m− l)2
σ
{i1,...,il}
IE
d−→ ∑
i∈{i1,...,il}
Zi
√
V arα1Ŷi(0,α1)/l2
σ
{i1,...,il}
IE
− ∑
i/∈{i1,...,il}
Zi
√
V arα1Ŷi(0,α1)/(m− l)2
σ
{i1,...,il}
IE
∼ N (0,1)
where the penultimate step follows from Proposition 1. The proofs for Propositions 4.3
and 4.4 are similar.
Proof of Propositions 5.1-5.4
To prove Proposition 5.1, let µGDE =
∑m
i=1DEi(α1)1(Gi = 1)/l and σ˜2DE =V ar{µGDE}.
Note µGDE =E{D̂E(α1)|G1, . . . ,Gm} and the assumptions of Proposition 5.1 imply that
σ
(0)
DE =
√
V ar{D̂E(α1)|G1, . . . ,Gm}. Therefore, because we assume that (2.9) holds for
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the sequence Wh = D̂Eih(α1)
∣∣∣Gi1 = · · · = Gil = 1, h = 1, . . . , l for any i1 6= . . . 6= il, it
follows that {D̂E(α1)−µGDE}/σ(0)DE
∣∣∣Gi1 = · · · = Gil = 1 d−→ N(0,1) for any i1 6= . . . 6= il.
Because the limiting distribution is the same regardless of G1, . . . ,Gm, it follows that
{D̂E(α1)−µGDE}/σ(0)DE d−→N(0,1). Note also this indicates that {D̂E(α1)−µGDE}/σ(0)DE
is asymptotically independent of G1, . . . ,Gm and thus asymptotically independent of
{µGDE −DE(α1)}/σ˜DE , which is a function of G1, . . . ,Gm. Next note that because
we assume DEi(α1) satisfies (2.10), Lehmann (1998) Appendix 4 Theorem 6 implies
{µGDE−DE(α1)}/σ˜DE d−→N(0,1). Note V ar{D̂E(α1)}= σ(0)2DE + σ˜2DE such that
D̂E(α1)−DE(α1)√
V ar{D̂E(α1)}
= σ
(0)
DE√
σ
(0)2
DE + σ˜2DE
D̂E(α1)−µGDE
σ
(0)
DE
+ σ˜DE√
σ
(0)2
DE + σ˜2DE
µGDE−DE(α1)
σ˜DE
Following Slutsky’s theorem, (2.5) is obtained. The proofs of Propositions 5.2-5.4 can
be derived along the same lines.
Details for Voting Experiment Analysis
For the voting experiment described in Section 2.5.2, we assume households were
independently assigned encouragement to vote with probability 0.5. This group-level
Bernoulli type randomization is different from the permutation randomization assumed
throughout the rest of the paper and therefore some adaptations of the various re-
sults are needed. First, it is helpful to re-express the estimators in an inverse prob-
ability weighted (IPW) form. Namely, now define Ŷ (z,αs) =
∑m
i=1 Ŷi(z,αs)1(Gi =
s)/{mPr(Gi = s)} and Ŷ (αs) =∑mi=1 Ŷi(αs)1(Gi = s)/{mPr(Gi = s)}, where Ŷi(z,αs)
and Ŷi(αs) are defined as before. When the group-level assignment entails permutation
randomization, these IPW estimators are equivalent to those presented in Section 2.3.1.
Assuming group-level Bernoulli randomization, it is straightforward to show the IPW
estimators are unbiased. Deriving the limiting distributions of the IPW estimators is
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also straightforward because G1, . . . ,Gn are independent under group-level Bernoulli
randomization. For example, if (2.9) holds for Wh = D̂Eh(α1)1(Gh = 1)/Pr(Gh = 1),
h= 1, . . . ,m, then it follows immediately that (2.5) holds as m→∞; similarly, if (2.9)
holds for Wh = Ŷh(0,α1)1(Gh = 1)/Pr(Gh = 1)− Ŷh(0,α0)1(Gh = 0)/Pr(Gh = 0), then
it follows immediately that (2.6) holds as m→∞. Similar results can be obtained for
the total and overall effect IPW estimators. Note that no homogeneity assumptions
are required here, in contrast to when there is permutation group-level randomization.
Computing Wald and Chebyshev CIs requires estimating the variances of the dif-
ferent IPW estimators. For the direct effect one possible estimator is V̂ ar{D̂E(α1)}=∑m
i=1 D̂E
2
i (α1)1(Gi = 1)/{m2Pr(Gi = 1)2}, which is a positively biased estimator for
V ar{D̂E(α1)} with bias ∑mi=1DE2i (α1)/m2. To see this, note
V ar{D̂E(α1)} = E
[
V ar{D̂E(α1)|G1, . . . ,Gm}
]
+V ar
[
E{D̂E(α1)|G1, . . . ,Gm}
]
=
m∑
i=1
E
[
V arα1D̂Ei(α1)1(Gi = 1)
]
m2Pr(Gi = 1)2
+
m∑
i=1
V ar
[
DEi(α1)1(Gi = 1)
mPr(Gi = 1)
]
=
m∑
i=1
V arα1D̂Ei(α1)
m2Pr(Gi = 1)
+
m∑
i=1
DE
2
i (α1){1−Pr(Gi = 1)}
m2Pr(Gi = 1)
=
m∑
i=1
Eα1D̂E
2
i (α1)
m2Pr(Gi = 1)
−
m∑
i=1
DE
2
i (α1)
m2
= E
{ m∑
i=1
D̂E
2
i (α1)1(Gi = 1)
m2Pr(Gi = 1)2
}
−
m∑
i=1
DE
2
i (α1)
m2
whereEα1D̂E
2
i (α1) =E{D̂E
2
i (α1)|Gi = 1}. Similarly, one can define V̂ ar{ÎE(α1,α0)}=∑m
i=1 Ŷ
2
i (0,α1)1(Gi = 1)/{m2Pr2(Gi = 1)}+ Ŷ 2i (0,α0)1(Gi = 0)/{m2Pr2(Gi = 0)},
V̂ ar{T̂E(α1,α0)}=∑mi=1 Ŷ 2i (1,α1)1(Gi = 1)/{m2Pr2(Gi = 1)}+ Ŷ 2i (0,α0)1(Gi = 0)/
{m2Pr2(Gi = 0)} and V̂ ar{ÔE(α1,α0)} = ∑mi=1 Ŷ 2i (α1)1(Gi = 1)/{m2Pr2(Gi = 1)}+
Ŷ 2i (α0)1(Gi = 0)/{m2Pr2(Gi = 0)}, as positively biased estimators for V ar{ÎE(α1,α0)},
V ar{T̂E(α1,α0)} and V ar{ÔE(α1,α0)} with bias ∑mi=1{yi(0,α1)−yi(0,α0)}2/m2,
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∑m
i=1{yi(1,α1)− yi(0,α0)}2/m2 and
∑m
i=1{yi(α1)− yi(α0)}2/m2 respectively. Because
these variance estimators are positively biased, Wald and Chebyshev CIs constructed
using these estimators (as in the lower part of Table 2.5) are expected in practice to be
conservative, i.e., cover with probability greater 1−γ.
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Appendix II
Proofs from Chapter 3
Proof of Proposition 1
Note
EŶ ipw(z,αk) = E
[
E{Ŷ ipw(z,αk)|Li}
]
= n−1E
n∑
i=1
∑
zi,si
yi(zi, si)1(zi = z)pi(si,αk)
f(zi, si|Li) f(zi, si|Li)
= n−1E
n∑
i=1
∑
si
yi(z,si)pi(si,αk)
= y(z,αk)
The unbiasness for Ŷ ipw(αk) can be proved in the same line
Proof of Proposition 2
To prove the asymptotic Normality of Ŷ ipw(z,αk), note that this estimator is the
solution to estimating equation Gipwn (µ) = 0 where
Gipwn (µ) =
n∑
i=1
{
yi(Zi,Si)1(Zi = z)pi(Si;αk)
f(Zi,Si|Li) −µ
}
Large-sample properties for IPW estimators follow from the general framework of M-
estimation thoery (Stefanski and Boos 2002 and Lunceford and Davidian 2004). We
only sketch out some key steps here. By Taylor expansion, 0 = Gipwn (µˆ) = Gipwn (µ) +
G˙ipwn (µ)(µˆ− µ) + op(1), we have
√
n(µˆ− µ) = {−G˙ipwn (µ)/n}−1n−1/2Gipwn (µ) + op(1).
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Note that G˙ipwn (µ)/n→E{G˙ipwn (µ)/n} and that n−1/2Gipwn (µ) d−→N(0,V ar{Gipwn (µ)}/n)
as n→∞ thus√n(µˆ−µ)/σipw d−→N(0,1), where (σipw)2 =V ar{Gipwn (µ)}E{−G˙ipwn (µ)/n}−2
/n=V ar{Gipwn (µ)}/n=E{Gipwn (µ)}2/n=
∑m
v=1Eψ
2
v/n. Similarly, note that Ŷ
haj
h (z,αk)
is the solution of the estimating equation Ghajh,n (µ) = 0, where
Ghajh,n (µ) =
n∑
i=1
yi(Zi,Si)pi(Si;αk)1(Zi = z)
f(Zi,Si|Li) −µnˆh,z
The remainder of the proof of (b) and (c) follows along the same lines as the proof of
(a).
Proof of Proposition 3
To prove (a), let θ = (µ,γ,σ2b )T , then θˆ = {Yˆ ipw(z,αk), γˆ, σˆ2b}T is the solution of the
vector equation Gipwn = 0, where Gipwn =
∑m
v=1{|Cv|(Yˆ ipwv (z,αk)−µ),∂lv}T , where for
the notation convenience we write ∂·= {∂ ·/∂γ,∂ ·/∂σ2b}. Then
∂Yˆ ipwv (z,αk)
∂γ
= |Cv|−1 ∂
∂γ
∑
i∈Cv
yi(Zi,Si)1(Zi = z)pi(Si;αk)
f(Zi,Si|Li)
= −|Cv|−1
∑
i∈Cv
yi(Zi,Si)1(Zi = z)pi(Si;αk)
f2(Zi,Si|Li)
∂f(Zi,Si|Li)
∂γ
= −|Cv|−1
∑
i∈Cv
yi(Zi,Si)1(Zi = z)pi(Si;αk)
f(Zi,Si|Li)
∂/∂γf(Zi,Si|Li)
f(Zi,Si|Li)
= −|Cv|−1
∑
i∈Cv
yi(Zi,Si)1(Zi = z)pi(Si;αk)
f(Zi,Si|Li)
∂lv
∂γ
=−Yˆ ipwv (z,αk)
∂lv
∂γ
Similarly, ∂Yˆ ipwv (z,αk)/∂σ2b =−Yˆ ipwv (z,αk)∂lv/∂σ2b , i.e., ∂Yˆ ipwv (z,αk) =−Yˆ ipwv (z,αk)∂lv.
Thus,
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E{
∂Gipwn
∂θ
}
=−
m∑
v=1
 |Cv| |Cv|EYˆ ipwv (z,αk)∂lv
0 E∂lTv ∂lv

=−
 n
∑m
v=1 |Cv|EYˆ ipwv (z,αk)∂lv
0 ∑mv=1E∂lTv ∂lv

i.e.,
{
−E∂G
ipw
n
∂θ
}−1
=

n−1 − m∑
v=1
|Cv|EYˆ ipwv (z,αk)∂lv/n{
m∑
v=1
E∂lTv ∂lv}−1
0 { m∑
v=1
E∂lTv ∂lv}−1

Note that
E{Gipwn Gipwn
T}=
m∑
v=1
 |Cv|2E(Yˆ ipwv (z,αk)−µ)2 |Cv|E(Yˆ ipwv (z,αk)−µ)∂lv|Cv|E(Yˆ ipwv (z,αk)−µ)∂lv E∂lTv ∂lv

=
m∑
v=1
 |Cv|2E(Yˆ ipwv (z,αk)−µ)2 |Cv|EYˆ ipwv (z,αk)∂lv|Cv|EYˆ ipwv (z,αk)∂lTv E∂lTv ∂lv

Thus,
{ 1
n
E
∂Gipwn
∂θ
}−1
E{Gipwn Gipwn
T
/n}
{ 1
n
E
∂Gipwn
∂θ
}−T
=
 (σipw)2−Hipw
T
V −1
γ,σ2b
Hipw ∗
∗ ∗

where Hipw =∑mv=1EYˆ ipwv (z,αk)∂lTv /n is a vector, Vγ,σ2b =∑mv=1E∂lTv ∂lv/n and ∗ de-
notes some number which we do not express explicitly. Thus, when the propensity scores
are unknown, we have (σipw∗ )2 = (σipw)2−HipwTV −1γ,σ2bH
ipw. And since Vγ,σ2b is positive
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definite, so does V −1
γ,σ2b
and thus HipwTV −1
γ,σ2b
Hipw ≥ 0, which concludes (σipw∗ )2≤ (σipw)2.
To prove (b), note that θˆ = {Yˆ haj1 (z,αk), γˆ, σˆ2b}T is the solution to the vector equa-
tion Ghaj1,n = 0, where G
haj
1,n =
∑m
v=1{|Cv|Yˆ ipwv (z,αk)−µ
∑
i∈Cv pi(Zi;αk)/f(Zi|Li),∂lv}.
Also note that
E
∂
∂γ
{
Yˆ ipwv (z,αk)−µ
pi(Zi;αk)
f(Zi|Li)
}
= −E
{
Yˆ ipwv (z,αk)
∂lv
∂γ
−µpi(Zi;αk) ∂
∂γ
logf(Zi|Li)
}
Similarly, we have ∂{Yˆ ipwv (z,αk)−µpi(Zi;αk)/f(Zi|Li)}/∂σ2b =−{Yˆ ipwv (z,αk)∂lv/∂σ2b−
µpi(Zi;αk)∂ logf(Zi|Li)/∂σ2b}. Thus,
E
{
∂Ghaj1,n
∂θ
}
=−

n − m∑
v=1
E∂ψhaj1,v
0
m∑
v=1
E∂lTv ∂lv

whereE∂ψhaj1,v =E∂{|Cv|Yˆ ipwv (z,αk)−
∑
i∈Cv µpi(Zi;αk)/f(Zi|Li)}=−E{|Cv|Yˆ ipwv (z,αk)∂lv
−∑i∈Cv ∂ logf(Zi|Li)µpi(Zi;αk)}. i.e.,
{
−E∂G
haj
1,n
∂θ
}−1
=

n−1
m∑
v=1
E∂ψhaj1,v /n{
m∑
v=1
E∂lTv ∂lv}−1
0 { m∑
v=1
E∂lTv ∂lv}−1

Note that
E{Ghaj1,nGhaj1,n
T}=
m∑
v=1
 E(ψ
haj
1,v )2 Eψ
haj
1,v ∂lv
Eψhaj1,v ∂l
T
v E∂l
T
v ∂lv

Thus, (σhaj1,∗ )2 = (σ
haj
1 )2+2ATV −1γ,σ2bH
haj
1 +H
haj
1
T
V −1
γ,σ2b
Hhaj1 , whereA=
∑m
v=1Eψ
haj
1,v ∂l
T
v /n
and Hhaj1 =
∑m
v=1E∂ψ
haj
1,v
T
/n.
To prove (c), note that θˆ= {Yˆ haj2 (z,αk), γˆ, σˆ2b}T is the solution to the vector equation
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Ghaj2,n = 0, whereG
haj
2,n =
∑m
v=1{|Cv|[Yˆ ipwv (z,αk)−µ1(Zi = z)pi(Si;αk)/f(Zi,Si|Li)],∂lv}T .
Also note that
∂
∂γ
{
Yˆ ipwv (z,αk)−µ
1(Zi = z)pi(Si;αk)
f(Zi,Si|Li)
}
= −
{
Yˆ ipwv (z,αk)−µ
1(Zi = z)pi(Si;αk)
f(Zi,Si|Li)
}
∂lv
∂γ
Similar as in the proof for Proposition 3, we have (σhaj2,∗ )2 = (σ
haj
2 )2−Hhaj2
T
V −1
γ,σ2b
Hhaj2 ,
where Hhaj2 =
∑m
v=1E{Yˆ ipwv (z,αk)−µ1(Zi = z)pi(Si;αk)/f(Zi,Si|Li)}∂lv/n.
Derivations for variance of IPW and Hajek estimators and their estimators
assuming (3.5)
We derive the formula for ∂lv. Recall that lv = lv(γ,σ2b ) = log
∫ ∏
i∈Cv e
Zi
i (1−ei)1−Ziφ(bv)dbv,
where ei = exp{Liγ+ bv}/(1 + exp{Liγ+ bv}) and φ(·) denotes the density function of
N(0,σ2b ). we have ∂ei/∂γ = ei(1− ei)Li and that
∂lv
∂γ
= 1
f({Zi : i ∈ Cv}|Li)
∫ ∏
i∈Cv
eZii (1− ei)1−Zi{
∑
i∈Cv
Zi− ei
ei(1− ei)
∂ei
∂γ
}φ(bv)dbv
= 1
f({Zi : i ∈ Cv}|Li)
∫ ∏
i∈Cv
eZii (1− ei)1−Zi{
∑
i∈Cv
(Zi− ei)Li}φ(bv)dbv
=
∑
i∈Cv
ZiLi−
∫
f({Zi : i ∈ Cv}|Li, bv)φ(bv){∑i∈Cv eiLi}dbv
f({Zi : i ∈ Cv}|Li)
Note that ∂φ(bv)/∂σ2b = σ
−2
b φ(bv){b2v/σ2b −1}/2 and thus
∂lv
∂σ2b
=
∫
f({Zi : i ∈ Cv}|Li, bv)φ(bv)b2vdbv
2σ4bf({Zi : i ∈ Cv}|Li)
− 12σ2b
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Similarly, we have
∂ logf(Zi|Li)
∂γ
= ZiLi−
∫
f(Zi|Li, bv)φ(bv)eiLidbv
f(Zi|Li)
and that
∂ logf(Zi|Li)
∂σ2b
=
∫
f(Zi|Li, bv)φ(bv)b2vdbv
2σ4bf(Zi|Li)
− 12σ2b
Finally, note that Hˆipw = ∑mv=1 Yˆ ipwv (z,αk)∂ˆlTv /n, Vˆγ,σ2b = ∑mv=1 ∂ˆlTv ∂ˆlv/n are con-
sistent estimators for Hipw, Vγ,σ2b , where ∂ˆlv(γ,σ
2
b ) = ∂lv(γˆ, σˆ2b ).
Proof of Propositions 4-5
To prove (a) in Proposition 4, recall that D̂Ehajh (αk) = g(Ŷ
haj
h (1,αk), Ŷ
haj
h (0,αk))
and note that µˆ= {µˆ1, µˆ0}T for µˆz = Ŷ ipw(z,αk) is the solution for estimating equation
Gipwn (µ) = {Gipwn (µ1),Gipwn (µ0)}T = 0, where Gipwn (µz) =
∑m
v=1 |Cv|(Yˆ ipwv (z,αk)−µz).
Similar as in the proof of Proposition 2, we have
√
n(µˆ−µ) = {−G˙ipwn (µ)}−1
√
nGipwn (µ)+
op(1). The Normality of µˆ and thus D̂E
ipw(αk) = g(µˆ1, µˆ0) is obtained for continuous
function g. Further we have (σD,ipw)2 =∇gV ar{Ghajh,n (µ)}∇gT /n =
m∑
v=1
Eψ2v/n, where
ψv = ψD,ipwv (αk) =5g(ψipwv (1,αk),ψipwv (0,αk))T . The proofs of Propositions 4(b), 4(c)
and 5 can be derived similarly.
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Appendix III
Proofs from Chapter 4
Proof of Proposition 1
To prove (a), notice that θˆ = (Ŷ DR(a,αk), γˆ, βˆ)T is the solution of estimating e-
quation Gm(θ) = (
∑m
i=1ψi(η,γ,β),Sγ ,Sβ)T = 0, Sγ and Sβ are log-likelihood func-
tions from which we obtained γˆ and βˆ. By Taylor expansion, 0 = Gm(θˆ) = Gm(θ) +
G˙m(θ)(θˆ− θ) +op(1), we have √m(θˆ− θ) = {−G˙m(θ)/m}−1m−1/2Gm(θ) +op(1). Note
that m−1/2{Gm(θ)−EGm(θ)} d−→N(0,Σ), where Σ = limm→∞EGm(θ)GTm(θ)/m. Since
ESγ = 0 and ESβ = 0, we next show that Eψi(η,γ,β)→ 0 and thus EGm(θ)→ 0 when
either γ∗ = γ0 or β∗ = β0.
If γˆ→ γ0, then fˆ(Ai|Xi) p−→ f(Ai|Xi) and thus
E
1(A= a)Y (Ai)fˆ(Ai|Xi) pi(Ai(−j);α0)
→ y(a,α0)
Also note that
E
 ∑
ai(−j)
µˆ(ai,Xi)pi(ai(−j);α0)−
1(A= a)µˆ(Ai,Xi)
fˆ(Ai|Xi)
pi(Ai(−j);α0)

= E
 ∑
ai(−j)
µˆ(ai,Xi)pi(ai(−j);α0)
−E
1(A= a)µˆ(Ai,Xi)fˆ(Ai|Xi) pi(Ai(−j);α0)

= E
∑
a(−i)
µˆ(ai,Xi)pi(ai(−j);α0)
−E
∑
ai
µˆ(a,ai(−j),Xi)
fˆ(a,ai(−j)|Xi)
pi(ai(−j);α0)Pr(a,ai(−j)|Xi)

→ E
∑
a(−i)
µˆ(ai,Xi)pi(ai(−j);α0)
−E
 ∑
ai(−j)
µˆ(a,ai(−j),Xi)pi(ai(−j);α0)
= 0
which leads to Eψi→ 0.
If β∗→ β0 then µˆ(ai,Xi) p−→ µ(ai,Xi) and thus
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E ∑
ai(−j)
µˆ(a,ai(−j),Xi)pi(ai(−j);α0)
→ y(a,α0)
Also note that
E
1(Aij = a){Y (Ai)− µˆ(Ai,Xi)}fˆ(Ai|Xi) pi(Ai(−j);α0)
→ 0
which also leads to Eψi→ 0. Thus, we have m−1/2Gm(θ) d−→N(0,Σ).
We next derive G˙m(θ). Note that ∂ψi/∂η =−1 and that
m−1
m∑
i=1
∂ψi
∂γ
p−→ m−1
m∑
i=1
E
∂ψi
∂γ
= 1
ni
ni∑
j=1
E
−1(Aij = a)f(Ai|Xi) ∂µ(Ai,Xi)∂γ +
∑
ai(−j)
∂µ(a,ai(−j),Xi)
∂γ
pi(ai(−j);α0)

= 0
Similarly,
m−1
m∑
i=1
∂ψi
∂β
p−→ m−1
m∑
i=1
E
∂ψi
∂β
= 1
ni
ni∑
j=1
E
{
1(Aij = a){Y (Ai)−µ(Ai,Xi)}
fˆ(Ai|Xi)
∂ logf(Ai|Xi)
∂β
pi(Ai(−j);α0)
}
= 1
ni
ni∑
j=1
E
{
1(Aij = a)E{Y (Ai)−µ(Ai,Xi)|Ai,Xi}
fˆ(Ai|Xi)
∂ logf(Ai|Xi)
∂β
pi(Ai(−j);α0)
}
= 0
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Thus,
G˙m(θ)/m
p−→−

1 0 0
0 ∗ ∗
0 ∗ ∗

i.e.,
{G˙m(θ)/m}−1 p−→−

1 0 0
0 ∗ ∗
0 ∗ ∗

where ∗ denotes some number we do not express explicitly. Thus, we have the desired
result. The proof for (b) can be obtained in a similar fashion.
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